Publikationen

2022

Hänscheid H, Schirbel A,Hartrampf P, Kraus S, Werner RA, Einsele H, Wester HJ, Lassmann M, Kortüm M, Buck AK (2022)
Biokinetics and Dosimetry of 177Lu-Pentixather.
J Nucl Med 63(5): 754-760.

Buck AK, Haug A, Dreher N, Lambertini A, Higuchi T, Lapa C, Weich A, Pomper MG, Wester HJ, Zehndner A, Schirbel A, Samnick S, Hacker M, Pichler V, Hahner S, Fassnacht M, Einsele H, Serfling SE, Werner RA (2022)
Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using 68Ga-Pentixafor PET.
J Nucl Med 63(11): 1687-1692.

Hahner S, Hartrampf PE, Mihatsch PW, Nauerz M, Heinze B, Hänscheid H, Teresa Fuß C, Werner RA, Pamporaki C, Kroiss M, Fassnacht M, Buck AK, Schirbel A (2022)
Targeting 11-Beta Hydroxylase With [131I]IMAZA: A Novel Approach for the Treatment of Advanced Adrenocortical Carcinoma.
J Clin Endocrinol Metab. 107(4): e1348-e1355.

Hartrampf PE, Weinzierl FX, Buck AK, Rowe SP, Higuchi T, Seitz AK, Kübler H, Schirbel A, Essler M, Bundschuh RA, Werner RA (2022)
Matched-pair analysis of [177Lu]Lu-PSMA I&T and [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer.
Eur J Nucl Med Mol Imaging 49(9): 3269-3276.

Schumann S, Scherthan H, Pfestroff K, Schoof S, Pfestroff A, Hartrampf P, Hasenauer N, Buck AK, Luster M, Port M, Lassmann M, Eberlein U (2022)
DNA damage and repair in peripheral blood mononuclear cells after internal ex vivo irradiation of patient blood with 131I.
Eur J Nucl Med Mol Imaging 49(5): 1447-1455.

2021

Schumann S, Eberlein U, Lapa C, Müller J, Serfling S, Lassmann M, Scherthan H (2021)
α-Particle-induced DNA damage tracks in peripheral blood mononuclear cells of [223Ra]RaCl2-treated prostate cancer patients.
Eur J Nucl Med Mol Imaging 48(9): 2761-2770.

Israel I, Elflein K, Schirbel A, Chen K, Samnick S (2021)
A comparison of the monomeric [68Ga]NODAGA-NGR and dimeric [68Ga]NOTA-(NGR)2 as aminopeptidase N ligand for positron emission tomography imaging in tumor-bearing mice.
Eur J Pharm Sci 166(2021 Nov 1;166:105964).

Werner RA, Derlin T, Rowe SP, Bundschuh L, Sheikh GT, Pomper MG, Schulz S, Higuchi T, Buck AK, Bengel FM, Bundschuh RA, Lapa C (2021)
High Interobserver Agreement for the Standardized Reporting System SSTR-RADS 1.0 on Somatostatin Receptor PET/CT.
J Nucl Med 62(4): 514-520.

Heinze B, Schirbel A, Nannen L, Michelmann D, Hartrampf PE, Bluemel C, Schneider M, Herrmann K, Haenscheid H, Fassnacht M, Buck AK, Hahner S (2021)
Novel CYP11B-ligand [123/131I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience.
Eur J Nucl Med Mol Imaging 49(1): 301-310.

Schlötelburg W, Ebert I, Petritsch B, Weng AM, Dischinger U, Kircher S, Buck AK, Bley TA, Deutschbein T, Fassnacht M (2021)
Adrenal wash-out CT: moderate diagnostic value in distinguishing benign from malignant adrenal masses.
Eur J Endocrinol 186(2): 183-193.

Michalski K, Ruf J, Goetz C, Seitz AK, Buck AK, Lapa C, Hartrampf PE (2021)
Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy.
Eur J Nucl Med Mol Imaging 48(6): 2024-2030.

Giesel FL, Kratochwil C, Schlittenhardt J, Dendl K, Eiber M, Staudinger F, Kessler L, Fendler WP, Lindner T, Koerber SA, Cardinale J, Sennung D, Roehrich M, Debus J, Sathekge M, Haberkorn U, Calais J, Serfling S, Buck AL (2021)
Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET/CT in cancer patients.
Eur J Nucl Med Mol Imaging 48(13): 4377-4385.

Duell J, Krummenast F, Schirbel A, Klassen P, Samnick S, Rauert-Wunderlich H, Rasche L, Buck AK, Wester HJ, Rosenwald A, Einsele H, Topp MS, Lapa C, Kircher M (2021)
Improved Primary Staging of Marginal-Zone Lymphoma by Addition of CXCR4-Directed PET/CT.
J Nucl Med  62(10): 1415-1421.

Tran-Gia J, Denis-Bacelar AM, Ferreira KM, Robinson AP, Calvert N, Fenwick AJ, Finocchiaro D, Fioroni F, Grassi E, Heetun W, Jewitt SJ, Kotzassarlidou M, Ljungberg M, McGowan DR, Scott N, Scuffham J, Gleisner KS, Tipping J, Wevrett J, MRTDosimetry Collaboration, Lassmann M (2021)
A multicentre and multi-national evaluation of the accuracy of quantitative Lu-177 SPECT/CT imaging performed within the MRTDosimetry project.
EJNMMI Phys 8(1).

2020

Lehmacher M, Stolzenburg A, Samnick S (2020)
Uptake of [¹⁸F]tetrafluoroborate in MCF-7 Breast Cancer Cells is Induced after Stimulation of the Sodium Iodide Symporter.
Curr Cancer Drug Targets 20(2): 146-155.

Kircher M, Tran-Gia J, Kemmer L, Zhang X, Schirbel A,Werner RA, Buck AK, Wester HJ, Hacker M, Lapa C, Li X (2020)
Imaging Inflammation in Atherosclerosis with CXCR4-Directed 68Ga-Pentixafor PET/CT: Correlation with 18F-FDG PET/CT.
J Nucl Med 61(5): 751-756.

Tran-Gia J, Salas-Ramirez M, Lassmann M (2020)
What You See Is Not What You Get: On the Accuracy of Voxel-Based Dosimetry in Molecular Radiotherapy.
J Nucl Med 61(8): 1178-1186.

Chen X, Fritz A, Werner RA, Nose N, Yagi Y, Kimura H, Rowe SP, Koshino K, Decker M, Higuchi T (2020)
Initial Evaluation of AF78: a Rationally Designed Fluorine-18-Labelled PET Radiotracer Targeting Norepinephrine Transporter.
Mol Imaging Biol 22(3): 602-611.

Höhn F, Hammer S, Fellner C, Zeman F, Uller W, Brill R, Guntau M, Wildgruber M, Wohlgemuth WA (2020)
3T MRI of Peripheral Vascular Malformations: Characteristics and Comparison of Two Fat-Saturated sequences: Short Tau Inversion Recovery Versus Three-Dimensional High-Resolution Volume Interpolated Gradient Recalled Echo.
Rofo.

2019

Hänscheid H, Kircher M, Schirbel A, Wunderlich G, Werner RA,Samnick S, Kotzerke J, Einsele H, Buck AK, Wester HJ, Grigoleit GU (2019)
Feasibility of CXCR4-Directed Radioligand Therapy in Advanced Diffuse Large B-Cell Lymphoma.
J Nucl Med 60:60-64.

Tran-Gia J, Lassmann M (2019)
Characterization of Noise and Resolution for Quantitative 177Lu SPECT/CT with xSPECT Quant.
J Nucl Med 60:50-59.

Werner RA, Wakabayashi H, Bauer J, Schütz C, Zechmeister C, Hayakawa N, Javadi MS, Lapa C, Jahns R, Ergün S, Jahns V, Higuchi T (2019)
Longitudinal 18F-FDG PET imaging in a rat model of autoimmune myocarditis.
Eur Heart J Cardiovasc Imaging 20:467-474.

2018

Samnick S, Al-Momani E, Schmid JS, Mottok A, Buck AK, Lapa C (2018)
Initial Clinical Investigation of [18F]Tetrafluoroborate PET/CT in Comparison to [124I]Iodine PET/CT for Imaging Thyroid Cancer.
Clin Nucl Med 43:162-167.

2016

Reich MM, Brumberg J, Pozzi NG, Marotta G, Roothans J, Åström M, Musacchio T, Lopiano L, Lanotte M, Lehrke R, Buck AK, Volkmann J, Isaias IU (2016)
Progressive gait ataxia following deep brain stimulation for essential tremor: adverse effect or lack of efficacy?
Brain 139:2948-2956.

2015

Bluemel C, Cramer A, Grossmann C, Kajdi GW, Malzahn U, Lamp N, Langen HJ, Schmid J, Buck AK, Grimminger HJ, Herrmann K (2015)
iROLL: does 3-D radioguided occult lesion localization improve surgical management in early-stage breast cancer?
Eur J Nucl Med Mol Imaging 42:1692-1699.

Eberlein U, Scherthan H, Bluemel C, Peper M, Lapa C, Buck AK, Port M, Lassmann M (2015)
DNA Damage in Peripheral Blood Lymphocytes of Thyroid Cancer Patients After Radioiodine Therapy.
J Nucl Med.57:173-179.

Herrmann K, Bluemel C, Weineisen M, Schottelius M, Wester HJ, Czernin J, Eberlein U, Beykan S, Lapa C, Riedmiller H, Krebs M, Kropf S, Schirbel A, Buck AK, Lassmann M (2015)
Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapy.
J Nucl Med 56:855-861.

Philipp-Abbrederis K, Herrmann K, Knop S, Schottelius M, Eiber M, Lückerath K, Pietschmann E, Habringer S, Gerngroß C, Franke K, Rudelius M, Schirbel A, Lapa C, Schwamborn K, Steidle S, Hartmann E, Rosenwald A, Kropf S, Beer AJ, Peschel C, Einsele H, Buck AK, Schwaiger M, Götze K, Wester HJ, Keller U (2015)
In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma.
EMBO Mol Med 7:477-487.

2014

Lapa C, Lückerath K, Malzahn U, Samnick S, Einsele H, Buck AK, Herrmann K, Knop S (2014)
18FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation.
Oncotarget 5:7381-7391.

Schmidt AMA, Grunz JP, Petritsch B, Gruschwitz P, Knarr J, Huflage H, Bley TA, Kosmala A (2022)
Combination of Iterative Metal Artifact Reduction and Virtual Monoenergetic Reconstruction Using Split-Filter Dual-Energy CT in Patients With Dental Artifact on Head and Neck CT.
AJR Am J Roentgenol 218(4): 716-727.

Ihne S, Kircher M, Papagianni A, Goetze O, Morbach C, Werner RA, Zeller D, Sommer C, Rosenwald A, Amann K, Linke RP, Lapa C, Einsele H, Geier A, Obici L, Palladini G, Knop S, Störk S (2022)
AA amyloidosis in inflammatory active malignant paraganglioma.
Amyloid 29(2): 137-138.

Skazel T, Buck AK, Lassmann M, Kerner T, Schaelte G, Heller AR, Hossfeld B, Graesner JT, Meybohm P, Wurmb T (2022)
Organisation and clinical management of radio-nuclear incidents.
Anasthesiol Intensivmed 63(): 17-25.

Wenz J, Arndt F, Samnick S (2022)
A robust [11C]acetate synthesis on a TRACERLab FX C pro module.
Appl Radiat Isot 188().

Hartrampf PE, Krebs M, Peter L, Heinrich M, Ruffing J, Kalogirou C, Weinke M, Brumberg J, Kübler H, Buck AK, Werner RA, Seitz AK (2022)
Reduced Segmentation of Lesions Is Comparable to Whole-Body Segmentation for Response Assessment by PSMA PET/CT: Initial Experience with the Keyhole Approach.
Biology (Basel) 11(5).

Böckle D, Tabares P, Zhou X, Schimanski S, Steinhardt MJ, Bittrich M, Seebacher E, Ulbrich M, Wilnit A, Metz C, Heidemeier A, Bley T, Werner R, Buck A, Einsele H, Kortüm KM, Beilhack A, Rasche L (2022)
Minimal residual disease and imaging-guided consolidation strategies in newly diagnosed and relapsed refractory multiple myeloma.
Br J Haematol 2022; 198(3): 515-522.

Kosmala A, Serfling SE, Dreher N, Lindner T, Schirbel A, Lapa C, Higuchi T, Buck AK, Weich A, Werner RA (2022)
Associations between Normal Organs and Tumor Burden in Patients Imaged with Fibroblast Activation Protein Inhibitor-Directed Positron Emission Tomography.
Cancers (Basel) 14(11).

Mihatsch PW, Beissert M, Pomper MG, Bley TA, Seitz AK, Kübler H, Buck AK, Rowe SP, Serfling SE, Hartrampf PE, Werner RA (2022)
Changing Threshold-Based Segmentation Has No Relevant Impact on Semi-Quantification in the Context of Structured Reporting for PSMA-PET/CT.
Cancers (Basel) 14(2).

Tamihardja J, Zehner L, Hartrampf PE, Cirsi S, Wegener S, Buck AK, Flentje M, Polat B (2022)
Dose-Escalated Salvage Radiotherapy for Macroscopic Local Recurrence of Prostate Cancer in the Prostate-Specific Membrane Antigen Positron Emission Tomography Era.
Cancers (Basel) 14(19).

Hartrampf PE, Weinzierl FX, Serfling SE, Pomper MG, Rowe SP, Higuchi T, Seitz AK, Kübler H, Buck AK, Werner RA (2022)
Hematotoxicity and Nephrotoxicity in Prostate Cancer Patients Undergoing Radioligand Therapy with [177Lu]Lu-PSMA I&T.
Cancers (Basel) 14(3).

Tamihardja J, Zehner L, Hartrampf P, Lisowski D, Kneitz S, Cirsi S, Razinskas G, Flentje M, Polat B (2022)
Salvage Nodal Radiotherapy as Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer Detected by Positron Emission Tomography Shows Favorable Outcome in Long-Term Follow-Up.
Cancers (Basel) 14(15).

Bertero E, Dudek J, Cochain C, Delgobo M, Ramos G, Gerull B, Higuchi T, Vaeth M, Zernecke A, Frantz S, Hofmann U, Maack C (2022)
Immuno-metabolic interfaces in cardiac disease and failure.
Cardiovasc Res 118(1): 37-52.

Lenschow C, Hendricks A, Buck A, Werner RA, Schlegel N (2022)
Is [11C]-choline PET CT superior to [11C]-methionine PET CT in detecting of parathyroid adenomas in primary hyperparathyroidism?
Chirurgie (Heidelb) 93(12): 1175-1175.

Serfling SE, Hartrampf PE, Zhi Y, Higuchi T, Rowe SP, Bundschuh L, Essler M, Buck AK, Bundschuh RA, Werner RA (2022)
Interobserver Agreement Rates on Fibroblast Activation Protein Inhibitor-Directed Molecular Imaging and Therapy.
Clin Nucl Med 47(6): 512-516.

Weich A, Werner RA, Serfling SE, Solnes LB, Pomper MG, Buck AK, Higuchi T, Rowe SP (2022)
Rechallenge With Additional Doses of 177 Lu-DOTATOC After Failure of Maintenance Therapy With Cold Somatostatin Analogs.
Clin Nucl Med 47(8): 719-720.

Hasenauer N, Higuchi T, Deschler-Baier B, Hartrampf PE, Pomper MG, Rowe SP, Fassnacht M, Buck AK, Werner RA (2022)
Visualization of Tumor Heterogeneity in Advanced Medullary Thyroid Carcinoma by Dual-Tracer Molecular Imaging: Revealing the Theranostic Potential of SSTR- and PSMA-Directed Endoradiotherapy.
Clin Nucl Med 47(7): 651-652.

Higuchi T, Serfling SE, Rowe SP, Werner RA (2022)
Therapeutic Effects of Lipid Lowering Medications on Myocardial Blood Flow, Inflammation, and Sympathetic Nerve Activity Using Nuclear Techniques.
Curr Cardiol Rep.

Werner RA, Hartrampf PE, Schirbel A, Hahner S (2022)
Adrenal functional imaging - which marker for which indication?
Curr Opin Urol 32(6): 585-593.

Leube J, Gustafsson J, Lassmann M, Salas-Ramirez M, Tran-Gia J (2022)
Analysis of a deep learning-based method for generation of SPECT projections based on a large Monte Carlo simulated dataset.
EJNMMI Phys 9(1).

Serfling SE, Zhi Y, Megerle F, Fassnacht M, Buck AK, Lapa C, Werner RA (2022)
Somatostatin receptor-directed molecular imaging for therapeutic decision-making in patients with medullary thyroid carcinoma.
Endocrine 78(1): 169-176.

van Velsen EFS, Peeters RP, Stegenga MT, Mäder U, Reiners C, van Kemenade FJ, van Ginhoven TM, Visser WE, Verburg FA (2022)
Evaluating the use of a two-step age-based cutoff for the UICC/AJCC TNM staging system in patients with papillary or follicular thyroid cancer.
Eur J Endocrinol 186(3): 389-397.

Dudek JJ, Kutschka IKI, Bertero EBE, Erk MEM, Arslan BAB, Meier PMP, Schmitz WSW, Rehling PRP, Xiao KXK, Thum TTT, Yang LYLF, Rabinowitz JRJ, Higuchi THT, Maack CMC (2022)
Metabolic remodeling to compensate defects in energy conversion and redox homeostasis due to dysfunctional mitochondria in barth syndrome cardiomyopathy.
Eur J Heart Fail 24 Suppl 1(): 7-8.

Hustinx R, Pruim J, Lassmann M, Visvikis D (2022)
An EANM position paper on the application of artificial intelligence in nuclear medicine.
Eur J Nucl Med Mol Imaging 50(1): 61-66.

Visvikis D, Lambin P, Beuschau Mauridsen K, Hustinx R, Lassmann M, Rischpler C, Shi K, Pruim J (2022)
Application of artificial intelligence in nuclear medicine and molecular imaging: a review of current status and future perspectives for clinical translation.
Eur J Nucl Med Mol Imaging 49(13): 4452-4463.

Schumann S, Scherthan H, Schoof S, Hartrampf PE, Buck AK, Port M, Lassmann M, Eberlein U (2022)
Are There Differences in DNA Damage Induction and Repair Before and After Radioiodine Therapy?
Eur J Nucl Med Mol Imaging 49 Suppl 1(SUPPL 1): S146-S146.

Hartrampf PE, Seitz AK, Weinzierl FX, Serfling SE, Schirbel A, Rowe SP, Kübler H, Buck AK, Werner RA (2022)
Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [177Lu]Lu-PSMA I&T during long-term follow-up.
Eur J Nucl Med Mol Imaging 49(12): 4262-4270. 

Lambertini A, Hartrampf PE, Higuchi T, Serfling SE, Meybohm P, Schirbel A, Buck AK, Werner RA (2022)
CXCR4-targeted molecular imaging after severe SARS-Cov-2 infection.
Eur J Nucl Med Mol Imaging 50(1): 228-229.

Buck AK, Serfling SE, Lindner T, Hänscheid H, Schirbel A, Hahner S, Fassnacht M, Einsele H, Werner RA (2022)
CXCR4-targeted theranostics in oncology.
Eur J Nucl Med Mol Imaging 49(12): 4133-4144.

Schumann S, Scherthan H, Pfestroff K, Schoof S, Pfestroff A, Hartrampf P, Hasenauer N, Buck AK, Luster M, Port M, Lassmann M, Eberlein U (2022)
DNA damage and repair in peripheral blood mononuclear cells after internal ex vivo irradiation of patient blood with 131I.
Eur J Nucl Med Mol Imaging 49(5): 1447-1455.

Strobel I, Scherthan H, Muller J, Schumann S, Buck AK, Port M, Lassmann M, Eberlein U (2022)
DNA damage repair in PBMCs after simultaneous internal ex vivo irradiation with [Ra-223]RaCl2and [Lu-177]LuCl3.
Eur J Nucl Med Mol Imaging 49 Suppl 1(SUPPL 1): S207-S207.

Cytawa W, Kircher S, Kübler H, Werner RA, Weber S, Hartrampf P, Bandurski T, Lass P, Połom W, Matuszewski M, Wester HJ, Lapa C, Rosenwald A, Seitz AK, Buck AK (2022)
Diverse PSMA expression in primary prostate cancer: reason for negative [68Ga]Ga-PSMA PET/CT scans? Immunohistochemical validation in 40 surgical specimens.
Eur J Nucl Med Mol Imaging 49(11): 3938-3949.

Sjögreen Gleisner K, Chouin N, Gabina PM, Cicone F, Gnesin S, Stokke C, Konijnenberg M, Cremonesi M, Verburg FA, Bernhardt P, Eberlein U, Gear J (2022)
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands.
Eur J Nucl Med Mol Imaging 49(6): 1778-1809.

Ramirez MS, Lassmann M, Tran-Gia J (2022)
Effect of Kilovoltage and Quality Reference mAs on CT-Based Attenuation Correction in Lu-177 SPECT/CT Imaging: a Phantom Study.
Eur J Nucl Med Mol Imaging 49 Suppl 1(SUPPL 1): S265-S265.

Boeser J, Faller H, Lukasczik M, Weisbrodt J, Werner RA, Buck A (2022)
Emotional state of patients with prostate cancer during PSMA-PET/CT.
Eur J Nucl Med Mol Imaging 49 Suppl 1(SUPPL 1): S692-S692.

Bauer N, Todica A, Pfob C, Fenzl L, Beyer L, Wenter V, Bartenstein P, Buck A, Werner R, Lapa C, Hartrampf P (2022)
Impact of interim PET staging with SSTR-analogs after two cycles of Lu-177-PRRT in NET patients: a multicenter analysis
Eur J Nucl Med Mol Imaging 49 Suppl 1(SUPPL 1): S80-S80.

Gil AV, Taprogge J, Vallot D, Eberlein U, Lassmann M, Schurrat T, Ashfaq A, Flux GD, Bardies M (2022)
Implementing dosimetry in a multicentric environment: Results of the MEDIRAD project.
Eur J Nucl Med Mol Imaging 49 Suppl 1(SUPPL 1): S145-S146.

Muhlig S, Chen X, Tutov A, Werner R, Decker M, Higuchi T (2022)
Investigation of crucial influence of the meta-substituted analogs of a potential game changer-F-18-AF78, a novel PET radiotracer trageting NET.
Eur J Nucl Med Mol Imaging 49 Suppl 1(SUPPL 1): S324-S324.

Hartrampf PE, Weinzierl FX, Buck AK, Rowe SP, Higuchi T, Seitz AK, Kübler H, Schirbel A, Essler M, Bundschuh RA, Werner RA (2022)
Matched-pair analysis of [177Lu]Lu-PSMA I&T and [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer.
Eur J Nucl Med Mol Imaging 49(9): 3269-3276.

Kurth J, Rahbar K, Eiber M, Sparks R, Baca N, Krause BJ, Lassmann M, Jentzen W, Chicco D, Klein P, Blumenstein L, Basque J, Herrmann K (2022)
Multi- cycle dosimetry of [Lu-177]Lu-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer: results from the VISION trial sub-study.
Eur J Nucl Med Mol Imaging 2022; 49 Suppl 1(SUPPL 1): S129-S129. 

Leube J, Horn M, Hartrampf P,Lassmann M, Tran-Gia J (2022) 
PET-based pre-segmentation improves deep learning-based automated renal segmentation based on only CT.
Eur J Nucl Med Mol Imaging 49 Suppl 1(SUPPL 1): S285-S285.

Beykan S, Haenscheid H, Hahner S, Buck AK, Lassmann M, Schirbel A (2022)
Patient-Specific Biodistribution and Tumor Dosimetry of [I-131]IMAZA in Patients with Adrenal Tumors.
Eur J Nucl Med Mol Imaging 49 Suppl 1(SUPPL 1): S391-S391.

Göring L, Schumann S, Müller J, Buck AK, Port M, Lassmann M, Scherthan H, Eberlein U (2022)
Repair of α-particle-induced DNA damage in peripheral blood mononuclear cells after internal ex vivo irradiation with 223Ra.
Eur J Nucl Med Mol Imaging 49(12): 3981-3988.

Reinecke MJ, Ahlers G, Burchert A, Eilsberger F, Flux GD, Marlowe RJ, Mueller HH, Reiners C, Rohde F, van Santen HM, Luster M (2022)
Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma - a critical review and evaluation of the existing evidence.
Eur J Nucl Med Mol Imaging 49(9): 3247-3256.

Dickson J, Cremonesi M, Denis-Bacelar AM, Hristova I, Koole M, Peters S, Gleisner KS, Tran-Gia J, Lassmann M (2022)
The EARL Quantitative(177)Lu-SPECT-CT accreditation programme.
Eur J Nucl Med Mol Imaging 49 Suppl 1(SUPPL 1): S187-S187.

Zehnder A, Pickel S, Bouterfa H, Berroteran-Infante N, Castillo J, Reis H, Kaufmann J, Janz A, Buck A (2022)
The FORPAN Study: A future international, prospective, multicenter Phase III Study to evaluate the diagnostic performance and safety of a new PET Tracer [Ga-68]Ga-PentixaFor for detection and localization of chemokine receptor 4 (CXCR4) positive tumors and their metastases in a PAN Cancer approach.
Eur J Nucl Med Mol Imaging 49 Suppl 1(SUPPL 1): S410-S410.

Dickson J, Eberlein U, Lassmann M (2022)
The effect of modern PET technology and techniques on the EANM paediatric dosage card.
Eur J Nucl Med Mol Imaging 49(6): 1964-1969.

Hartrampf PE, Bundschuh RA, Weinzierl FX, Serfling SE, Kosmala A, Seitz AK, Kübler H, Buck AK, Essler M, Werner RA (2022)
mCRPC patients with PSA fluctuations under radioligand therapy have comparable survival benefits relative to patients with sustained PSA decrease.
Eur J Nucl Med Mol Imaging 49(13): 4727-4735.

Heidemeier A, Schloetelburg W, Thurner A, Metz C, Heidemeier H, Rasche L, Martin Kortuem K, Boeckle D, Weiland E, Benkert T, Nickel D, Werner R, Buck AK, Bley TA (2022)
Multi-parametric whole-body MRI evaluation discerns vital from non-vital multiple myeloma lesions as validated by 18F-FDG and 11C-methionine PET/CT.
Eur J Radiol 155().

Krämer SD, Schuhmann MK, Schadt F, Israel I, Samnick S, Volkmann J, Fluri F (2022)
Changes of cerebral network activity after invasive stimulation of the mesencephalic locomotor region in a rat stroke model.
Exp Neurol 347().

Andree A, Li N, Butenko K, Kober M, Chen JZ, Higuchi T, Fauser M, Storch A, Ip CW, Kühn AA, Horn A, van Rienen U (2022)
Deep brain stimulation electrode modeling in rats.
Exp Neurol 350().

Voter AF, Werner RA, Pienta KJ, Gorin MA, Pomper MG, Solnes LB, Rowe SP (2022)
Piflufolastat F-18 (18F-DCFPyL) for PSMA PET imaging in prostate cancer.
Expert Rev Anticancer Ther 22(7): 681-694.

Aster HC, Romanos M, Walitza S, Gerlach M, Mühlberger A, Rizzo A, Andreatta M, Hasenauer N, Hartrampf PE, Nerlich K, Reiners C, Lorenz R, Buck AK, Deserno L (2022)
Responsivity of the Striatal Dopamine System to Methylphenidate-A Within-Subject I-123-β-CIT-SPECT Study in Male Children and Adolescents With Attention-Deficit/Hyperactivity Disorder.
Front Psychiatry 13().

Tolstik E, Ali N, Guo S, Ebersbach P, Möllmann D, Arias-Loza P, Dierks J, Schuler I,
Freier E, Debus J, Baba HA, Nordbeck P, Bocklitz T, Lorenz K (2022)
CARS Imaging Advances Early Diagnosis of Cardiac Manifestation of Fabry Disease.
Int J Mol Sci 2022; 23(10).

Ostheim P, Miederer M, Schreckenberger M, Nestler T, Hoffmann MA, Lassmann M, Eberlein U, Barsegian V, Rump A, Majewski M, Port M, Abend M (2022)
mRNA and small RNA gene expression changes in peripheral blood to detect internal Ra-223 exposure.
Int J Radiat Biol 98(5): 900-912.

Ohto T, Tayeh AA, Nishikomori R, Abe H, Hashimoto K, Baba S, Arias-Loza AP, Soda N, Satoh S, Matsuda M, Iizuka Y, Kondo T, Koseki H, Yan N, Higuchi T, Fujita T, Kato H (2022)
Intracellular virus sensor MDA5 mutation develops autoimmune myocarditis and nephritis.
J Autoimmun 127().

Gram M, Gensler D, Albertova P, Gutjahr FT, Lau K, Arias-Loza PA, Jakob PM,
Nordbeck P (2022)
Quantification correction for free-breathing myocardial T1ρ mapping in mice using a
recursively derived description of a T1ρ* relaxation pathway.
J Cardiovasc Magn Reson 2022; 24(1).

Hahner S, Hartrampf PE, Mihatsch PW, Nauerz M, Heinze B, Hänscheid H, Teresa Fuß C, Werner RA, Pamporaki C, Kroiss M, Fassnacht M, Buck AK, Schirbel A (2022)
Targeting 11-Beta Hydroxylase With [131I]IMAZA: A Novel Approach for the Treatment of Advanced Adrenocortical Carcinoma.
J Clin Endocrinol Metab. 107(4): e1348-e1355.

Herrmann K, Rahbar K, Eiber M, Krause BJ, Lassmann M, Jentzen W, Blumenstein L, Klein P, Basque JR, Kurth J (2022)
Dosimetry of Lu-177-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer: results from the VISION trial sub-study.
J Clin Oncol 40 Suppl S(6).

Linz C, Brands RC, Hackenberg S, Hartmann S, Iring T, Hohm J, Haug L, Kertels O, Kircher M, Dierks A, Buck AK, Brumberg J, Lapa C (2022)
[18F]FDG-PET/CT improves the detection of synchronous malignancies at primary staging of oral squamous cell carcinoma - A retrospective study.
J Craniomaxillofac Surg 50(8): 671-676.

Weich A, Wild V, Higuchi T, Meining A, Rowe S, Pomper M, Mielert K, Rosenwald A, Scheurlen M, Buck A, Serfling S, Werner R (2022)
Fibroblast Activation Protein (FAP)-directed molecular imaging segregates between subtypes of poorly differentiated neuroendocrine neoplasms.
J Neuroendocrinol 34 Suppl 1(): 162-162.

Luger AL, König S, Samp PF, Urban H, Divé I, Burger MC, Voss M, Franz K, Fokas E, Filipski K, Demes MC, Stenzinger A, Sahm F, Reuss DE, Harter PN, Wagner S, Hattingen E, Wichert J, Lapa C, Fröhling S, Steinbach JP, Ronellenfitsch MW (2022)
Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysis.
J Neurooncol 159(2): 243-259.

Werner RA, Higuchi T (2022)
Calcitonin gene-related peptide (CGRP)-induced recovery after myocardial infarction: Is there a role for CGRP-targeted molecular image-guided strategies in cardiology?
J Nucl Cardiol 29(5): 2100-2102.

Werner RA, Martinez RB, Marcus C, Kruse MJ, Sheikhbahaei S, Solnes LB, Higuchi T, Javadi MS, Rowe SP (2022)
Diagnostic performance of IQ·SPECT with high-speed scanning: A preliminary quality control study in obese patients.
J Nucl Cardiol. 

Werner RA, Rowe SP, Higuchi T (2022)
No major impact of prescribed CAD drugs on myocardial perfusion uptake derived by [82]rubidium PET.
J Nucl Cardiol 29(6): 2863-2865.

Kraus S, Dierks A, Rasche L, Kertels O, Kircher M, Schirbel A, Zovko J, Steinbrunn T, Tibes R, Wester HJ, Buck AK, Einsele H, Kortüm KM, Rosenwald A, Lapa C (2022)
68Ga-Pentixafor PET/CT for Detection of Chemokine Receptor CXCR4 Expression in Myeloproliferative Neoplasms.
J Nucl Med 63(1): 96-99.

Hänscheid H, Schirbel A, Hartrampf P, Kraus S, Werner RA, Einsele H, Wester HJ, Lassmann M, Kortüm M, Buck AK (2022)
Biokinetics and Dosimetry of 177Lu-Pentixather.
J Nucl Med 63(5): 754-760.

Buck AK, Haug A, Dreher N, Lambertini A, Higuchi T, Lapa C, Weich A, Pomper MG, Wester HJ, Zehndner A, Schirbel A, Samnick S, Hacker M, Pichler V, Hahner S, Fassnacht M, Einsele H, Serfling SE, Werner RA (2022)
Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using 68Ga-Pentixafor PET.
J Nucl Med 63(11): 1687-1692.

Theisen AL, Lassmann M, Tran-Gia J (2022)
Toward a Patient-Specific Traceable Quantification of SPECT/CT-Based Radiopharmaceutical Distributions.
J Nucl Med 63(7): 1108-1116.

Thieme A, Maurus K, Ernestus K, Hirsch S, Schramm K, Wirth C, Buck A, Härtel C, Schlegel PG, Eyrich M, Woelfl M, Classen CF, Wiegering VA (2022)
Secondary Biphenotypic Acute Leukemia Following Rosai-Dorfman-Disease A Coincidence?Klin Padiatr 234(3): 169-171.

Lenschow C, Wennmann A, Hendricks A, Germer CT, Fassnacht M, Buck A, Werner RA, Plassmeier L, Schlegel N (2022)
Questionable value of [99mTc]-sestamibi scintigraphy in patients with pHPT and negative ultrasound.
Langenbecks Arch Surg 407(8): 3661-3669.

Bögelein A, Stolzenburg A, Eiring P, Lückerath K, Munawar U, Werner R, Schirbel A, Samnick S, Kortüm KM, Sauer M, Lapa C, Buck AK (2022)
CXCR4 expression of multiple myeloma as a dynamic process: influence of therapeutic agents.
Leuk Lymphoma 63(10): 2393-2402.

Gram M, Gensler D, Winter P, Seethaler M, Arias-Loza PA, Oberberger J, Jakob PM,
Nordbeck P (2022)
Fast myocardial T1ρ mapping in mice using k-space weighted image contrast and a Bloch simulation-optimized radial sampling pattern.
MAGN RESON MATER PHY 2022; 35(2): 325-340.

Pelzer T, Buck A, Gernert M, Giner T, Haarmann A, Jung P (2022)
[Sarcoidosis - the chameleon of internal medicine].
MMW Fortschr Med 164(13): 52-59.

Werner RA, Habacha B, Lütje S, Bundschuh L, Higuchi T, Hartrampf P, Serfling SE, Derlin T, Lapa C, Buck AK, Essler M, Pienta KJ, Eisenberger MA, Markowski MC, Shinehouse L, AbdAllah R, Salavati A, Lodge MA, Pomper MG, Gorin MA, Bundschuh RA, Rowe SP (2022)
High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with 18F-DCFPyL.
Mol Imaging 2022().

Matsusaka Y, Chen X, Arias-Loza P, Werner RA, Nose N, Sasaki T, Rowe SP, Pomper MG, Lapa C, Higuchi T (2022)
In Vivo Functional Assessment of Sodium-Glucose Cotransporters (SGLTs) Using [18F]Me4FDG PET in Rats.
Mol Imaging 2022().

Matsusaka Y, Werner RA, Arias-Loza P, Nose N, Sasaki T, Chen X, Lapa C, Higuchi T (2022)
Performance Evaluation of a Preclinical SPECT Scanner with a Collimator Designed for Medium-Sized Animals.
Mol Imaging 2022().

Serfling SE, Lapa C, Dreher N, Hartrampf PE, Rowe SP, Higuchi T, Schirbel A, Weich A, Hahner S, Fassnacht M, Buck AK, Werner RA (2022)
Impact of Tumor Burden on Normal Organ Distribution in Patients Imaged with CXCR4-Targeted [68Ga]Ga-PentixaFor PET/CT.
Mol Imaging Biol 24(4): 659-665.

Weich A, Higuchi T, Bundschuh RA, Lapa C, Serfling SE, Rowe SP, Pomper MG, Herrmann K, Buck AK, Derlin T, Werner RA (2022)
Training on Reporting and Data System (RADS) for Somatostatin-Receptor Targeted Molecular Imaging Can Reduce the Test Anxiety of Inexperienced Readers.
Mol Imaging Biol 24(4): 631-640.

Prieto-Garcia C, Hartmann O, Reissland M, Braun F, Bozkurt S, Pahor N, Fuss C, Schirbel A, Schülein-Völk C, Buchberger A, Calzado Canale MA, Rosenfeldt M, Dikic I, Münch C, Diefenbacher ME (2022)
USP28 enables oncogenic transformation of respiratory cells, and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K.
Mol Oncol 16(17): 3082-3106.

Fezeu F, Opara C, Djientcheu V, Fonkem E, Samnick S (2022)
CHALLENGES AND SOLUTIONS FOR ESTABLISHING A CNS TUMOR REGISTRY IN AFRICA.
Neuro-oncol 24 Suppl 2().

Guggenberger KV, Vogt ML, Rowe SP, Higuchi T, Schmalzing M, Tony HP, Buck AK, Bley TA, Fröhlich M, Werner RA (2022)
Clinical Utility of C-Reactive Protein and White Blood Cell Count for Scheduling an [18F]FDG PET/CT in Patients with Giant Cell Arteritis.
Nuklearmedizin 61(6): 425-432.

Rowe SP, Buck A, Bundschuh RA, Lapa C, Serfling SE, Derlin T, Higuchi T, Gorin MA, Pomper MG, Werner RA (2022)
[18F]DCFPyL PET/CT for Imaging of Prostate Cancer.
Nuklearmedizin 61(3): 240-246.

Zehnder A, Pickel S, Bouterfa H, Berroteran-Infante N, Buck A (2022)
Diagnostische Leistung und Sicherheit von [68Ga]Ga-PentixaFor zur Erkennung und Lokalisation von Chemokin Rezeptor 4 (CXCR4) positiven Tumoren und Metastasen in einem PAN Cancer Ansatz: eine prospektive, multizentrische, internationale, klinische Phase III Studie, die FORPAN Studie.
Oncology Research and Treatment 45 Suppl 2(SUPPL 2): 292-292.

Rowe SP, Salavati A, Werner RA, Pienta KJ, Gorin MA, Pomper MG, Solnes LB (2022)
18F-Labeled Radiotracers for Prostate-specific Membrane Antigen: Historical Perspective and Future Directions.
PET Clin 17(4): 585-593.

Beykan S, Tran-Gia J, Borup Jensen S, Lassmann M (2022)
Is a single late SPECT/CT based kidney 177Lu-dosimetry superior to hybrid dosimetry with sequential multiple time-point whole-body planar scans in combination with an early SPECT/CT?
Phys Med 100(): 39-50.

Kayal G, Chauvin M, Mora-Ramirez E, Clayton N, Vergara-Gil A, Tran-Gia J, Lassmann M, Calvert N, Tipping J, Struelens L, MRTDosimetry Collaboration , Bardiès M (2022)
Modelling SPECT auto-contouring acquisitions for 177Lu & 131I molecular radiotherapy using new developments in Geant4/GATE.
Phys Med 96(): 101-113.

Werner RA, Schirbel A, Buck AK, Fassnacht M, Hahner S (2022)
Adrenal functional imaging.
Presse Med 51(2).

Sadaghiani MS, Sheikhbahaei S, Werner RA, Pienta KJ, Pomper MG, Gorin MA, Solnes LB, Rowe SP (2022)
177 Lu-PSMA radioligand therapy effectiveness in metastatic castration-resistant prostate cancer: An updated systematic review and meta-analysis.
Prostate 82(7): 826-835.

Hartrampf PE, Weinzierl FX, Seitz AK, Kübler H, Essler M, Buck AK, Werner RA, Bundschuh RA (2022)
Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy.
Prostate 82(14): 1406-1412.

Werner RA, Higuchi T, Nose N, Toriumi F, Matsusaka Y, Kuji I, Kazuhiro K (2022)
Generative adversarial network-created brain SPECTs of cerebral ischemia are indistinguishable to scans from real patients.
Sci Rep 12(1).

Lisowski D, Trömel J, Lutyj P, Lewitzki V, Hartrampf PE, Polat B, Flentje M, Tamihardja J (2022)
Health-related quality of life and clinical outcome after radiotherapy of patients with intracranial meningioma.
Sci Rep 12(1).

Theysohn JM, Demircioglu A, Kleditzsch M, Ludwig JM, Weber M, Umutlu L, Li Y, Kircher M, Lapa C, Buck A, Koehler M, Wildgruber M, Lange CM, Palard X, Garin E, Herrmann K, Forsting M, Nensa F (2022)
Prediction of left lobe hypertrophy after right lobe radioembolization of the liver using a clinical data model with external validation.
Sci Rep 12(1).

Werner RA, Pomper MG, Buck AK, Rowe SP, Higuchi T (2022)
SPECT and PET Radiotracers in Renal Imaging.
Semin Nucl Med 52(4): 406-418.

Lapa C, Nestle U, Albert NL, Baues C, Beer A, Buck A, Budach V, Bütof R, Combs SE, Derlin T, Eiber M, Fendler WP, Furth C, Gani C, Gkika E, Grosu AL, Henkenberens C, Ilhan H, Löck S, Marnitz-Schulze S, Miederer M, Mix M, Nicolay NH, Niyazi M, Pöttgen C, Rödel CM, Schatka I, Schwarzenboeck SM, Todica AS, Weber W, Wegen S, Wiegel T, Zamboglou C, Zips D, Zöphel K, Zschaeck S, Thorwarth D, Troost EGC, Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGN (2022)
Correction to: Value of PET imaging for radiation therapy.
Strahlenther Onkol 198(1): 80-82.

Yagi Y, Kimura H, Kondo Y, Higuchi T (2022)
Novel synthesis of an [F-18]aryl boronic acid ester as a reagent for F-18-labeling via Suzuki coupling.
Tetrahedron Lett 104().

Chen X, Werner RA, Koshino K, Nose N, Mühlig S, Rowe SP, Pomper MG, Lapa C, Decker M, Higuchi T (2022)
Molecular Imaging-Derived Biomarker of Cardiac Nerve Integrity - Introducing High NET Affinity PET Probe 18F-AF78.
Theranostics 12(9): 4446-4458.

Kraus S, Klassen P, Kircher M, Dierks A, Habringer S, Gäble A, Kortüm KM, Weinhold N, Ademaj-Kospiri V, Werner RA, Schirbel A, Buck AK, Herhaus P, Wester HJ, Rosenwald A, Weber WA, Einsele H, Keller U, Rasche L, Lapa C (2022)
Reduced splenic uptake on 68Ga-Pentixafor-PET/CT imaging in multiple myeloma - a potential imaging biomarker for disease prognosis.
Theranostics 12(13): 5986-5994.

Garg T, Werner RA, Chung HW, Khatri W, Pienta KJ, Pomper MG, Gorin MA, Saad E, Rowe SP (2022)
Association of True Positivity with Serum Prostate-Specific Antigen Levels and Other Clinical Factors in Indeterminate PSMA-RADS-3A Lesions Identified on 18F-DCFPyL PET/CT Scans.
Tomography 8(6): 2639-2647.

Salas-Ramirez M, Lassmann M, Tran-Gia J (2022)
Quantification of the volume fraction of fat, water and bone mineral in spongiosa for red marrow dosimetry in molecular radiotherapy by using a dual-energy (SPECT/)CT.
Z Med Phys 32(4): 428-437.

Hartrampf P, Werner R, Buck A (2022)
[Theranostics for Well and Moderately Differentiated GEP-NEN].
Zentralbl Chir 147(3): 249-255.

Inagaki T, Pearson JT, Tsuchimochi H, Schwenke DO, Saito S, Higuchi T, Masaki T, Umetani K, Shirai M, Nakaoka Y (2021)
Evaluation of right coronary vascular dysfunction in severe pulmonary hypertensive rats using synchrotron radiation microangiography.
Am J Physiol Heart Circ Physiol 320(3): H1021-H1036.

Kredel M, Reinhold AK, Wirbelauer J, Muellges W, Kunze E, Rehn M, Wöckel A, Lassmann M, Markus CK, Meybohm P, Kranke P (2021)
[Pregnancy and Irreversible Loss of Brain Functions - Case Report].
Anasthesiol Intensivmed Notfallmed Schmerzther 56(7-08): 526-535.

Koshino K, Werner RA, Pomper MG, Bundschuh RA, Toriumi F, Higuchi T, Rowe SP (2021)
Narrative review of generative adversarial networks in medical and molecular imaging. Ann Transl Med 9(9).

Mei RC, Bracarda S, Emmett L, Farolfi A, Lambertini A, Fanti S, Castellucci P (2021)
Androgen deprivation therapy and its modulation of PSMA expression in prostate cancer: mini review and case series of patients studied with sequential [Ga-68]-Ga-PSMA-11 PET/CT
CLINICAL AND TRANSLATIONAL IMAGING 9(3): 215-220.

Hartrampf PE, Lapa C, Serfling SE, Buck AK, Seitz AK, Meyer PT, Ruf J, Michalski K (2021)
Development of Discordant Hypermetabolic Prostate Cancer Lesions in the Course of [177Lu]PSMA Radioligand Therapy and Their Possible Influence on Patient Outcome.
Cancers (Basel) 13(17).

Gentzsch C, Hoffmann M, Ohshima Y, Nose N, Chen X, Higuchi T, Decker M (2021)
Synthesis and Initial Characterization of a Selective, Pseudo-irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer.
ChemMedChem 16(9): 1427-1437.

Cytawa W, Hartrampf P, Lass P, Kircher M, Polat B, Buck AK, Lapa C (2021)
Theranostics: A "Must Have" in Every Prostate Cancer Center. Illustration of Two Clinical Cases and Review of the Literature.
Clin Genitourin Cancer 19(4): e235-e247.

Kertels O, Breun M, Hänscheid H, Kircher M, Hartrampf PE, Schirbel A, Monoranu CM, Ernestus RI, Buck AK, Löhr M, Matthies C, Lapa C (2021)
Peptide Receptor Radionuclide Therapy in Patients With Neurofibromatosis Type 2: Initial Experience.
Clin Nucl Med 46(6): e312-e316.

Lassmann M, Eberlein U, Tran-Gia J (2021)
Multicentre Trials on Standardised Quantitative Imaging and Dosimetry for Radionuclide Therapies.
Clin Oncol (R Coll Radiol) 33(2): 125-130.

Weich A, Werner RA, Buck AK, Hartrampf PE, Serfling SE, Scheurlen M, Wester HJ, Meining A, Kircher S, Higuchi T, Pomper MG, Rowe SP, Lapa C, Kircher M (2021)
CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas.
Diagnostics (Basel) 11(4).

Khatri W, Chung HW, Werner RA, Leal JP, Pienta KJ, Lodge MA, Gorin MA, Pomper MG, Rowe SP (2021)
Effect of Point-Spread Function Reconstruction for Indeterminate PSMA-RADS-3A Lesions on PSMA-Targeted PET Imaging of Men with Prostate Cancer.
Diagnostics (Basel) 11(4).

Werner RA, Higuchi T, Pomper MG, Rowe SP (2021)
Theranostics in Oncology-Thriving, Now More than Ever.
Diagnostics (Basel) 11(5).

Fröhlich M, Serfling S, Higuchi T, Pomper MG, Rowe SP, Schmalzing M, Tony HP, Gernert M, Strunz PP, Portegys J, Schwaneck EC, Gadeholt O, Weich A, Buck AK, Bley TA, Guggenberger KV, Werner RA (2021)
Whole-Body [18F]FDG PET/CT Can Alter Diagnosis in Patients with Suspected Rheumatic Disease.
Diagnostics (Basel) 11(11).

Tran-Gia J, Denis-Bacelar AM, Ferreira KM, Robinson AP, Calvert N, Fenwick AJ, Finocchiaro D, Fioroni F, Grassi E, Heetun W, Jewitt SJ, Kotzassarlidou M, Ljungberg M, McGowan DR, Scott N, Scuffham J, Gleisner KS, Tipping J, Wevrett J, MRTDosimetry Collaboration, Lassmann M (2021)
A multicentre and multi-national evaluation of the accuracy of quantitative Lu-177 SPECT/CT imaging performed within the MRTDosimetry project.
EJNMMI Phys 8(1).

Soares Machado JS, Tran-Gia J, Schloegl S, Buck AK, Lassmann M (2021)
Biokinetics, dosimetry and radiation risk in infants after Tc-99m-MAG3 scans (vol 8, 10, 2018).
EJNMMI Res 11(1).

Lewis R, Habringer S, Kircher M, Hefter M, Peuker CA, Werner R, Ademaj-Kospiri V, Gäble A, Weber W, Wester HJ, Buck A, Herhaus P, Lapa C, Keller U (2021)
Investigation of spleen CXCR4 expression by [68Ga]Pentixafor PET in a cohort of 145 solid cancer patients.
EJNMMI Res 11(1).

Mihatsch PW, Beissert M, Bley TA, Buck AK, Lapa C (2021)
Thyroid incidentalomas with increased focal 18F-FDG uptake in 18F-FDG PET/CT of a patient with multiple primary cancers.
Endocrine 73(2): 491-492.

Schlötelburg W, Ebert I, Petritsch B, Weng AM, Dischinger U, Kircher S, Buck AK, Bley TA, Deutschbein T, Fassnacht M (2021)
Adrenal wash-out CT: moderate diagnostic value in distinguishing benign from malignant adrenal masses.
Eur J Endocrinol 186(2): 183-193.

Janz A, Cirnu A, Leskien M, Seewald A, Ueda Y, Regensburger M, Kohlhaas M, Woersdoerfer P, Wagner N, Klopocki E, Higuchi T, Duff H, Maack C, Erguen S, Gerull B (2021)
Characterization of molecular mechanisms underlying dilated cardiomyopathy with ataxia (DCMA) using pluripotent stem cell (iPSC)-derived cardiomyocytes.
Eur J Heart Fail 23 Suppl 1(): 10-10.

Schumann S, Scherthan H, Pfestroff K, Schoof S, Pfestroff A, Hartrampf P, Hasenauer N, Buck AK, Luster M, Port M, Lassmann M, Eberlein U (2021)
A damage and repair in peripheral blood mononuclear cells after internal ex vivo irradiation of patient blood with 131I.
Eur J Nucl Med Mol Imaging.

Konijnenberg M, Herrmann K, Kobe C, Verburg F, Hindorf C, Hustinx R, Lassmann M (2021)
EANM position paper on article 56 of the Council Directive 2013/59/Euratom (basic safety standards) for nuclear medicine therapy.
Eur J Nucl Med Mol Imaging 48(1): 67-72.

Aerts A, Eberlein U, Holm S, Hustinx R, Konijnenberg M, Strigari L, van Leeuwen FWB, Glatting G, Lassmann M (2021)
EANM position paper on the role of radiobiology in nuclear medicine.
Eur J Nucl Med Mol Imaging 48(11): 3365-3377.

Giesel FL, Kratochwil C, Schlittenhardt J, Dendl K, Eiber M, Staudinger F, Kessler L, Fendler WP, Lindner T, Koerber SA, Cardinale J, Sennung D, Roehrich M, Debus J, Sathekge M, Haberkorn U, Calais J, Serfling S, Buck AL (2021)
Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET/CT in cancer patients.
Eur J Nucl Med Mol Imaging 48(13): 4377-4385.

Serfling S, Zhi Y, Schirbel A, Lindner T, Meyer T, Gerhard-Hartmann E, Lapa C, Hagen R, Hackenberg S, Buck AK, Scherzad A (2021)
Improved cancer detection in Waldeyer's tonsillar ring by 68Ga-FAPI PET/CT imaging.
Eur J Nucl Med Mol Imaging 48(4): 1178-1187.

Hänscheid H, Hartrampf PE, Schirbel A, Buck AK, Lapa C (2021)
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC.
Eur J Nucl Med Mol Imaging 48(8): 2566-2572.

Heinze B, Schirbel A, Nannen L, Michelmann D, Hartrampf PE, Bluemel C, Schneider M, Herrmann K, Haenscheid H, Fassnacht M, Buck AK, Hahner S (2021)
Novel CYP11B-ligand [123/131I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience.
Eur J Nucl Med Mol Imaging 49(1): 301-310.

Hartrampf PE, Petritsch B, Buck AK, Serfling SE (2021)
Pitfalls in PSMA-PET/CT: intensive bone marrow uptake in a case with polycythemia vera.
Eur J Nucl Med Mol Imaging 48(5): 1669-1670.

Michalski K, Ruf J, Goetz C, Seitz AK, Buck AK, Lapa C, Hartrampf PE (2021)
Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy.
Eur J Nucl Med Mol Imaging 48(6): 2024-2030.

Linz C, Brands RC, Kertels O, Dierks A, Brumberg J, Gerhard-Hartmann E, Hartmann S, Schirbel A, Serfling S, Zhi Y, Buck AK, Kübler A, Hohm J, Lapa C, Kircher M (2021)
Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [18F]FDG PET/CT and MRI.
Eur J Nucl Med Mol Imaging 2021; 48(12): 3951-3960.

Dickson J, Eberlein U, Lassmann M (2021)
The effect of modern PET technology and techniques on the EANM paediatric dosage card.
Eur J Nucl Med Mol Imaging.

Schumann S, Eberlein U, Lapa C, Müller J, Serfling S, Lassmann M, Scherthan H (2021)
α-Particle-induced DNA damage tracks in peripheral blood mononuclear cells of [223Ra]RaCl2-treated prostate cancer patients.
Eur J Nucl Med Mol Imaging 48(9): 2761-2770.

Israel I, Elflein K, Schirbel A, Chen K, Samnick S (2021)
A comparison of the monomeric [68Ga]NODAGA-NGR and dimeric [68Ga]NOTA-(NGR)2 as aminopeptidase N ligand for positron emission tomography imaging in tumor-bearing mice.
Eur J Pharm Sci 166().

Lenschow C, Fuss CT, Kircher S, Buck A, Kickuth R, Reibetanz J, Wiegering A, Stenzinger A, Hübschmann D, Germer CT, Fassnacht M, Fröhling S, Schlegel N, Kroiss M (2021)
Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical Management.
Front Endocrinol (Lausanne) 12().

Detomas M, Altieri B, Schlötelburg W, Appenzeller S, Schlaffer S, Coras R, Schirbel A, Wild V, Kroiss M, Sbiera S, Fassnacht M, Deutschbein T (2021)
Case Report: Consecutive Adrenal Cushing's Syndrome and Cushing's Disease in a Patient With Somatic CTNNB1, USP8, and NR3C1 Mutations.
Front Endocrinol (Lausanne) 12().

Reiners C, Drozd VM (2021)
Editorial: Differentiated Thyroid Cancer - Risk Adapted Therapy, Genetic Profiling and Clinical Staging.
Front Endocrinol (Lausanne) 12().

Schadt F, Israel I, Samnick S (2021)
Development and Validation of a Semi-Automated, Preclinical, MRI-Template Based PET Image Data Analysis Tool for Rodents.
Front Neuroinform 15().

Verburg FA, Amthauer H, Binse I, Brink I, Buck A, Darr A, Dierks C, Koch C, König U, Kreissl MC, Luster M, Reuter C, Scheidhauer K, Willenberg HS, Zielke A, Schott M (2021)
Questions and Controversies in the Clinical Application of Tyrosine Kinase Inhibitors to Treat Patients with Radioiodine-Refractory Differentiated Thyroid Carcinoma: Expert Perspectives.
Horm Metab Res 53(3): 149-160.

Hummel HD, Kufer P, Gruellich C, Seggewiss-Bernhardt R, Deschler-Baier B, Chatterjee M, Goebeler ME, Miller K, de Santis M, Loidl W, Dittrich C, Buck A, Lapa C, Thurner A, Wittemer-Rump S, Koca G, Boix O, Doecke WD, Finnern R, Kusi H, Ajavon-Hartmann A, Stienen S, Sayehli CM, Polat B, Bargou RC (2021)
Pasotuxizumab, a BiTE® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings.
Immunotherapy 13(2): 125-141.

Drozd V, Saenko V, Branovan DI, Brown K, Yamashita S, Reiners C (2021)
A Search for Causes of Rising Incidence of Differentiated Thyroid Cancer in Children and Adolescents after Chernobyl and Fukushima: Comparison of the Clinical Features and Their Relevance for Treatment and Prognosis.
Int J Environ Res Public Health 18(7).

Pfeuffer-Jovic E, Heyckendorf J, Reischl U, Bohle RM, Bley T, Buck A, Wilkens H, Schäfers HJ, Langen HJ, Held M (2021)
Pulmonary vasculitis due to infection with Mycobacterium goodii: A case report.
Int J Infect Dis 104(): 178-180.

Ostheim P, Miederer M, Schreckenberger M, Nestler T, Hoffmann MA, Lassmann M, Eberlein U, Barsegian V, Rump A, Majewski M, Port M, Abend M (2021)
mRNA and small RNA gene expression changes in peripheral blood to detect internal Ra-223 exposure.
Int J Radiat Biol (): 1-13.

Brumberg J, Kerstens V, Cselényi Z, Svenningsson P, Sundgren M, Fazio P, Varrone A (2021)
Simplified quantification of [18F]FE-PE2I PET in Parkinson's disease: Discriminative power, test-retest reliability and longitudinal validity during early peak and late pseudo-equilibrium.
J Cereb Blood Flow Metab 41(6): 1291-1300.

Hasegawa K, Koshino K, Higuchi T (2021)
Facile synthesis of 2-deoxy-2-[18 F]fluorosorbitol using sodium borohydride on aluminum oxide.
J Labelled Comp Radiopharm 64(1): 40-46.

Weich A, Schreiner J, Rogoll D, Werner RA, Meining A, Bumm T, Scheurlen M (2021)
Establishment and characterization of a new neuroendocrine carcinoma cell model.
J Neuroendocrinol 33 Suppl 1(): 32-32.

Werner RA, Higuchi T (2021)
Calcitonin gene-related peptide (CGRP)-induced recovery after myocardial infarction: Is there a role for CGRP-targeted molecular image-guided strategies in cardiology?
J Nucl Cardiol.

Werner RA, Rowe SP, Higuchi T (2021)
No major impact of prescribed CAD drugs on myocardial perfusion uptake derived by [82]rubidium PET.
J Nucl Cardiol.

Hänscheid H, Schirbel A, Hartrampf P, Kraus S, Werner RA, Einsele H, Wester HJ, Lassmann M, Kortüm M, Buck AK (2021)
Biokinetics and Dosimetry of [177Lu]Lu-Pentixather.
J Nucl Med.

Poli GL, Coca M, Torres L, Fahey F, Lassmann M, Chapple CL, Homolka P, Delis H (2021)
Developing and Implementing an Imaging Optimization Study in Pediatric Nuclear Medicine: Experience and Recommendations from an IAEA-Coordinated Research Project.
J Nucl Med 62(4): 570-576.

Lassmann M, Eberlein U, Gear J, Konijnenberg M, Kunikowska J (2021)
Dosimetry for Radiopharmaceutical Therapy: The European Perspective.
J Nucl Med 62(Suppl 3): 73S-79S.

Werner RA, Derlin T, Rowe SP, Bundschuh L, Sheikh GT, Pomper MG, Schulz S, Higuchi T, Buck AK, Bengel FM, Bundschuh RA, Lapa C (2021)
High Interobserver Agreement for the Standardized Reporting System SSTR-RADS 1.0 on Somatostatin Receptor PET/CT.
J Nucl Med 62(4): 514-520.

Duell J, Krummenast F, Schirbel A, Klassen P, Samnick S, Rauert-Wunderlich H, Rasche L, Buck AK, Wester HJ, Rosenwald A, Einsele H, Topp MS, Lapa C, Kircher M (2021)
Improved Primary Staging of Marginal-Zone Lymphoma by Addition of CXCR4-Directed PET/CT.
J Nucl Med  62(10): 1415-1421.

Theisen AL, Lassmann M, Tran-Gia J (2021)
Towards a patient-specific traceable quantification of SPECT/CT-based radiopharmaceutical distributions.
J Nucl Med.

Reiners C, Hänscheid H, Schneider R (2021)
High-dose radiation exposure and hypothyroidism: aetiology, prevention and replacement therapy.
J Radiol Prot 41(4).

Linz C, Brands RC, Herterich T, Hartmann S, Müller-Richter U, Kübler AC, Haug L, Kertels O, Bley TA, Dierks A, Buck AK, Lapa C, Brumberg J (2021)
Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/ Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity.
JAMA Netw Open 4(4).

Hendricks A, Lenschow C, Kroiss M, Buck A, Kickuth R, Germer CT, Schlegel N (2021)
Evaluation of diagnostic efficacy for localization of parathyroid adenoma in patients with primary hyperparathyroidism undergoing repeat surgery.
Langenbecks Arch Surg 406(5): 1615-1624.

Eissler C, Werner RA, Arias-Loza P, Nose N, Chen X, Pomper MG, Rowe SP, Lapa C, Buck AK, Higuchi T (2021)
The Number of Frames on ECG-Gated 18F-FDG Small Animal PET Has a Significant Impact on LV Systolic and Diastolic Functional Parameters.
Mol Imaging 2021().

Gentzsch C, Chen X, Spatz P, Košak U, Knez D, Nose N, Gobec S, Higuchi T, Decker M (2021)
Synthesis and Initial Characterization of a Reversible, Selective 18F-Labeled Radiotracer for Human Butyrylcholinesterase.
Mol Imaging Biol 23(4): 505-515.

Pozzi NG, Brumberg J, Todisco M, Minafra B, Zangaglia R, Bossert I, Trifirò G, Ceravolo R, Vitali P, Isaias IU, Fasano A, Pacchetti C (2021)
Striatal Dopamine Deficit and Motor Impairment in Idiopathic Normal Pressure Hydrocephalus.
Mov Disord 36(1): 124-132.

Brumberg J, Kuzkina A, Lapa C, Mammadova S, Buck A, Volkmann J, Sommer C, Isaias IU, Doppler K (2021)
Dermal and cardiac autonomic fiber involvement in Parkinson's disease and multiple system atrophy.
Neurobiol Dis 153().

Todisco M, Zangaglia R, Minafra B, Pisano P, Trifirò G, Bossert I, Pozzi NG, Brumberg J, Ceravolo R, Isaias IU, Fasano A, Pacchetti C (2021)
Clinical Outcome and Striatal Dopaminergic Function After Shunt Surgery in Patients With Idiopathic Normal Pressure Hydrocephalus.
Neurology 96(23): e2861-e2873.

Lapa C, Nestle U, Albert NL, Baues C, Beer A, Buck A, Budach V, Bütof R, Combs SE, Derlin T, Eiber M, Fendler WP, Furth C, Gani C, Gkika E, Grosu AL, Henkenberens C, Ilhan H, Löck S, Marnitz-Schulze S, Miederer M, Mix M, Nicolay NH, Niyazi M, Pöttgen C, Rödel CM, Schatka I, Schwarzenboeck SM, Todica AS, Weber W, Wegen S, Wiegel T, Zamboglou C, Zips D, Zöphel K, Zschaeck S, Thorwarth D, Troost EGC, “Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGN” (2021)
Value of PET imaging for radiation therapy.
Nuklearmedizin 60(5): 326-343.

Delis H, Homolka P, Chapple CL, Costa PR, Attalla E, Lubis LE, Sackey TA, Fahey F, Lassmann M, Poli GL (2021)
Developing and implementing a multi-modality imaging optimization study in paediatric radiology: Experience and recommendations from an IAEA coordinated research project.
Phys Med 82(): 255-265.

Savir-Baruch B, Werner RA, Rowe SP, Schuster DM (2021)
PET Imaging for Prostate Cancer.
Radiol Clin North Am 59(5): 801-811.

Höhn F, Hammer S, Fellner C, Zeman F, Uller W, Brill R, Guntau M, Wildgruber M, Wohlgemuth WA (2021)
3T MRI of Peripheral Vascular Malformations: Characteristics and Comparison of Two Fat-Saturated sequences: Short Tau Inversion Recovery Versus Three-Dimensional High-Resolution Volume Interpolated Gradient Recalled Echo.
Rofo 193(4): 446-458.

Nose N, Nogami S, Koshino K, Chen X, Werner RA, Kashima S, Rowe SP, Lapa C, Fukuchi K, Higuchi T (2021)
[18F]FDG-labelled stem cell PET imaging in different route of administrations and multiple animal species.
Sci Rep 11(1).

Lapa C, Nestle U, Albert NL, Baues C, Beer A, Buck A, Budach V, Bütof R, Combs SE, Derlin T, Eiber M, Fendler WP, Furth C, Gani C, Gkika E, Grosu AL, Henkenberens C, Ilhan H, Löck S, Marnitz-Schulze S, Miederer M, Mix M, Nicolay NH, Niyazi M, Pöttgen C, Rödel CM, Schatka I, Schwarzenboeck SM, Todica AS, Weber W, Wegen S, Wiegel T, Zamboglou C, Zips D, Zöphel K, Zschaeck S, Thorwarth D, Troost EGC, Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGN (2021)
Value of PET imaging for radiation therapy.
Strahlenther Onkol 197(9): 1-23.

Toyama Y, Werner RA, Ruiz-Bedoya CA, Ordonez AA, Takase K, Lapa C, Jain SK, Pomper MG, Rowe SP, Higuchi T (2021)
Current and future perspectives on functional molecular imaging in nephro-urology: theranostics on the horizon.
Theranostics 11(12): 6105-6119.

Van Velsen EFS, Visser WE, Stegenga MT, Mäder U, Reiners C, van Kemenade FJ, van Ginhoven TM, Verburg FA, Peeters RP (2021)
Finding the Optimal Age Cutoff for the UICC/AJCC TNM Staging System in Patients with Papillary or Follicular Thyroid Cancer.
Thyroid 31(7): 1041-1049.

Isaias IU, Brumberg J, Pozzi NG, Palmisano C, Canessa A, Marotta G, Volkmann J, Pezzoli G (2020)
Brain metabolic alterations herald falls in patients with Parkinson's disease.
Ann Clin Transl Neurol 7(4): 579-583.

Page L, Ullmann AJ, Schadt F, Wurster S, Samnick S (2020)
In Vitro Evaluation of Radiolabeled Amphotericin B for Molecular Imaging of Mold Infections.
Antimicrob Agents Chemother 64(7).

Brumberg J, Beckl M, Dierks A, Schirbel A, Krebs M, Buck A, Kübler H, Lapa C, Seitz AK (2020)
Detection Rate of 68Ga-PSMA Ligand PET/CT in Patients with Recurrent Prostate Cancer and Androgen Deprivation Therapy.
Biomedicines 8(11).

Arimitsu K, Yagi Y, Koshino K, Nishito Y, Higuchi T, Yasui H, Kimura H (2020)
Synthesis of 18F-labeled streptozotocin derivatives and an in-vivo kinetics study using positron emission tomography.
Bioorg Med Chem Lett 30(17).

Morales-Lozano MI, Viering O, Samnick S, Rodriguez-Otero P, Buck AK, Marcos-Jubilar M, Rasche L, Prieto E, Kortüm KM, San-Miguel J, Garcia-Velloso MJ, Lapa C (2020)
18F-FDG and 11C-Methionine PET/CT in Newly Diagnosed Multiple Myeloma Patients: Comparison of Volume-Based PET Biomarkers.
Cancers (Basel) 12(4).

Zhou X, Dierks A, Kertels O, Kircher M, Schirbel A, Samnick S, Buck AK, Knorz S, Böckle D, Scheller L, Messerschmidt J, Barakat M, Kortüm KM, Rasche L, Einsele H, Lapa C (2020)
18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features.
Cancers (Basel) 12(8)

Schumann S, Scherthan H, Frank T, Lapa C, Müller J, Seifert S, Lassmann M, Eberlein U (2020)
DNA Damage in Blood Leukocytes of Prostate Cancer Patients Undergoing PET/CT Examinations with [68Ga]Ga-PSMA I&T.
Cancers (Basel) 12(2).

Zhou X, Dierks A, Kertels O, Samnick S, Kircher M, Buck AK, Haertle L, Knorz S, Böckle D, Scheller L, Messerschmidt J, Barakat M, Truger M, Haferlach C, Einsele H, Rasche L, Kortüm KM, Lapa C (2020)
The Link between Cytogenetics/Genomics and Imaging Patterns of Relapse and Progression in Patients with Relapsed/Refractory Multiple Myeloma: A Pilot Study Utilizing 18F-FDG PET/CT.
Cancers (Basel) 12(9).

Hartrampf PE, Hänscheid H, Kertels O, Schirbel A, Kreissl MC, Flentje M, Sweeney RA, Buck AK, Polat B, Lapa C (2020)
Long-term results of multimodal peptide receptor radionuclide therapy and fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma.
Clin Transl Radiat Oncol 22(): 29-32.

Lehmacher M, Stolzenburg A, Samnick S (2020)
Uptake of [¹⁸F]tetrafluoroborate in MCF-7 Breast Cancer Cells is Induced after Stimulation of the Sodium Iodide Symporter.
Curr Cancer Drug Targets 20(2): 146-155.

Gear J, Chiesa C, Lassmann M, Gabiña PM, Tran-Gia J, Stokke C, Flux G, EANM Dosimetry Committee (2020)
EANM Dosimetry Committee series on standard operational procedures for internal dosimetry for 131I mIBG treatment of neuroendocrine tumours.
EJNMMI Phys 7(1).

Hoffmann JV, Janssen JP, Kanno T, Shibutani T, Onoguchi M, Lapa C, Grunz JP, Buck AK, Higuchi T (2020)
Performance evaluation of fifth-generation ultra-high-resolution SPECT system with two stationary detectors and multi-pinhole imaging
EJNMMI Phys 7(1).

Taprogge J, Leek F, Schurrat T, Tran-Gia J, Vallot D, Bardiès M, Eberlein U, Lassmann M, Schlögl S, Vergara Gil A, MEDIRAD WP3 Investigator Team , Flux GD (2020)
Setting up a quantitative SPECT imaging network for a European multi-centre dosimetry study of radioiodine treatment for thyroid cancer as part of the MEDIRAD project.
EJNMMI Phys 7(1).

Cytawa W, Seitz AK, Kircher S, Fukushima K, Tran-Gia J, Schirbel A, Bandurski T, Lass P, Krebs M, Połom W, Matuszewski M, Wester HJ, Buck AK, Kübler H, Lapa C (2020)
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer.
Eur J Nucl Med Mol Imaging 47(1): 168-177.

Hartrampf PE, Seitz AK, Krebs M, Buck AK, Lapa C (2020)
False-negative 18F-PSMA-1007 PET/CT in metastatic prostate cancer related to high physiologic liver uptake.
Eur J Nucl Med Mol Imaging 47(8): 2044-2046.

Serfling S, Zhi Y, Schirbel A, Lindner T, Meyer T, Gerhard-Hartmann E, Lapa C, Hagen R, Hackenberg S, Buck AK, Scherzad A (2020)
Improved cancer detection in Waldeyer's tonsillar ring by 68Ga-FAPI PET/CT imaging.
Eur J Nucl Med Mol Imaging.

Poli GL, Torres L, Coca M, Veselinovic M, Lassmann M, Delis H, Fahey F (2020)
Paediatric nuclear medicine practice: an international survey by the IAEA.
Eur J Nucl Med Mol Imaging 47(6): 1552-1563.

Michalski K, Ruf J, Goetz C, Seitz AK, Buck AK, Lapa C, Hartrampf PE (2020)
Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy.
Eur J Nucl Med Mol Imaging.

Palmisano C, Brandt G, Vissani M, Pozzi NG, Canessa A, Brumberg J, Marotta G, Volkmann J, Mazzoni A, Pezzoli G, Frigo CA, Isaias IU (2020)
Gait Initiation in Parkinson's Disease: Impact of Dopamine Depletion and Initial Stance Condition.
Front Bioeng Biotechnol 8().

Drozd V, Schneider R, Platonova T, Panasiuk G, Leonova T, Oculevich N, Shimanskaja I, Vershenya I, Dedovich T, Mitjukova T, Grelle I, Biko J, Reiners C (2020)
Feasibility Study Shows Multicenter, Observational Case-Control Study Is Practicable to Determine Risk of Secondary Breast Cancer in Females With Differentiated Thyroid Carcinoma Given Radioiodine Therapy in Their Childhood or Adolescence; Findings Also Suggest Possible Fertility Impairment in Such Patients.
Front Endocrinol (Lausanne) 11().

Chifu I, Heinze B, Fuss CT, Lang K, Kroiss M, Kircher S, Ronchi CL, Altieri B, Schirbel A, Fassnacht M, Hahner S (2020)
Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma.
Front Endocrinol (Lausanne) 11().

Steinhardt MJ, Zhou X, Krummenast F, Meckel K, Nickel K, Böckle D, Messerschmidt J, Knorz S, Dierks A, Heidemeier A, Lapa C, Einsele H, Rasche L, Kortüm KM (2020)
Sequential CD38 monoclonal antibody retreatment leads to deep remission in a patient with relapsed/refractory multiple myeloma.
Int J Immunopathol Pharmacol 34().

Teusch VI, Uller W, Manger F, Vill K, Piehler AP, Müller-Wille R, Goessman H, Hammer S, Wohlgemuth WA (2020)
Do patients clinically diagnosed with vascular malformations of 1 lower extremity benefit from imaging of both legs from pelvis to toe? A prospective MRI study.
J Am Acad Dermatol 82(4): 981-984.

Brumberg J, Kerstens V, Cselényi Z, Svenningsson P, Sundgren M, Fazio P, Varrone A (2020)
Simplified quantification of [18F]FE-PE2I PET in Parkinson's disease: Discriminative power, test-retest reliability and longitudinal validity during early peak and late pseudo-equilibrium.
J Cereb Blood Flow Metab.

Kroiss M, Megerle F, Kurlbaum M, Zimmermann S, Wendler J, Jimenez C, Lapa C, Quinkler M, Scherf-Clavel O, Habra MA, Fassnacht M (2020)
Objective Response and Prolonged Disease Control of Advanced Adrenocortical Carcinoma with Cabozantinib.
J Clin Endocrinol Metab 105(5).

Chen X, Kudo T, Lapa C, Buck A, Higuchi T (2020)
Recent advances in radiotracers targeting norepinephrine transporter: structural development and radiolabeling improvements.
J Neural Transm 127(6): 851-873.

Ando D, Yokota C, Koshino K, Yasuno F, Sato T, Yamamoto A, Odani H, Nakajima T, Higuchi T, Tatsumi E (2020)
Microstructural white matter changes following gait training with Hybrid Assistive Limb initiated within 1 week of stroke onset.
J Neurol Sci 415().

Werner RA (2020)
Cardiac innervation imaging as a risk stratification tool for potential device therapy candidates.
J Nucl Cardiol 27(5): 1798-1801.

Ruiz-Bedoya CA, Ordonez AA, Werner RA, Plyku D, Klunk MH, Leal J, Lesniak WG, Holt DP, Dannals RF, Higuchi T, Rowe SP, Jain SK (2020)
11C-PABA as a PET Radiotracer for Functional Renal Imaging: Preclinical and First-in-Human Study.
J Nucl Med 61(11): 1665-1671.

Herhaus P, Lipkova J, Lammer F, Yakushev I, Vag T, Slotta-Huspenina J, Habringer S, Lapa C, Pukrop T, Hellwig D, Wiestler B, Buck AK, Deckert M, Wester HJ, Bassermann F, Schwaiger M, Weber WA, Menze B, Keller U (2020)
CXCR4-Targeted PET Imaging of Central Nervous System B-Cell Lymphoma.
J Nucl Med 61(12): 1765-1771.

Werner RA, Derlin T, Rowe SP, Bundschuh L, Sheikh GT, Pomper MG, Schulz S, Higuchi T, Buck AK, Bengel FM, Bundschuh RA, Lapa C (2020)
High Interobserver Agreement for the Standardized Reporting System SSTR-RADS 1.0 on Somatostatin Receptor PET/CT.
J Nucl Med.

Kircher M, Tran-Gia J, Kemmer L, Zhang X, Schirbel A, Werner RA, Buck AK, Wester HJ, Hacker M, Lapa C, Li X (2020)
Imaging Inflammation in Atherosclerosis with CXCR4-Directed 68Ga-Pentixafor PET/CT: Correlation with 18F-FDG PET/CT.
J Nucl Med 61(5): 751-756.

Rowe SP, Li X, Trock BJ, Werner RA, Frey S, DiGianvittorio M, Bleiler JK, Reyes DK, Abdallah R, Pienta KJ, Gorin MA, Pomper MG (2020)
Prospective Comparison of PET Imaging with PSMA-Targeted 18F-DCFPyL Versus Na18F for Bone Lesion Detection in Patients with Metastatic Prostate Cancer.
J Nucl Med 61(2): 183-188.

Tran-Gia J, Salas-Ramirez M, Lassmann M (2020)
What You See Is Not What You Get: On the Accuracy of Voxel-Based Dosimetry in Molecular Radiotherapy.
J Nucl Med 61(8): 1178-1186.

Hänscheid H, Lassmann M (2020)
Will SPECT/CT Cameras Soon Be Able to Display Absorbed Doses? Dosimetry from Single-Activity-Concentration Measurements.
J Nucl Med 61(7): 1028-1029.

Hartrampf PE, Heinrich M, Seitz AK, Brumberg J, Sokolakis I, Kalogirou C, Schirbel A, Kübler H, Buck AK, Lapa C, Krebs M (2020)
Metabolic Tumour Volume from PSMA PET/CT Scans of Prostate Cancer Patients during Chemotherapy-Do Different Software Solutions Deliver Comparable Results?
J. Clin. Med. 9(5).

Reiners C, Biko J, Leonova T, Drozd V (2020)
Treatment of thyroid carcinoma after the Chernobyl power plant accident: a difficult balancing act.
Lancet 395(10229): E61-E61.

Ohki A, Saito S, Hirayama E, Takahashi Y, Ogawa Y, Tsuji M, Higuchi T, Fukuchi K (2020)
Comparison of Chemical Exchange Saturation Transfer Imaging with Diffusion-weighted Imaging and Magnetic Resonance Spectroscopy in a Rat Model of Hypoxic-ischemic Encephalopathy.
Magn Reson Med Sci 19(4): 359-365.

Chen X, Fritz A, Werner RA, Nose N, Yagi Y, Kimura H, Rowe SP, Koshino K, Decker M, Higuchi T (2020)
Initial Evaluation of AF78: a Rationally Designed Fluorine-18-Labelled PET Radiotracer Targeting Norepinephrine Transporter.
Mol Imaging Biol 22(3): 602-611.

Werner RA, Bundschuh RA, Bundschuh L, Lapa C, Yin Y, Javadi MS, Buck AK, Higuchi T, Pienta KJ, Pomper MG, Lodge MA, Gorin MA, Rowe SP (2020)
Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake.
Mol Imaging Biol 22(1): 190-197.

Sahakyan K, Li X, Lodge MA, Werner RA, Bundschuh RA, Bundschuh L, Kulkarni HR, Schuchardt C, Baum RP, Pienta KJ, Pomper MG, Ross AE, Gorin MA, Rowe SP (2020)
Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Intrapatient and Interpatient Variability of Normal Organ Uptake.
Mol Imaging Biol 22(1): 181-189.

Brumberg J, Schröter N, Blazhenets G, Frings L, Volkmann J, Lapa C, Jost WH, Isaias IU, Meyer PT (2020)
Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy.
NPJ Parkinsons Dis 2020; 6(1).

Da Via MC, Solimando AG, Garitano-Trojaola A, Barrio S, Munawar U, Strifler S, Haertle L, Rhodes N, Teufel E, Vogt C, Lapa C, Beilhack A, Rasche L, Einsele H, Kortüm KM (2020)
CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF-MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System Involvement.
Oncologist 25(2): 112-118.

Breuer K, Weick S, Stroehle SP, Breuer FA, Kleine P, Veldhoen S, Richter A, Lapa C, Flentje M, Polat B (2020)
Feasibility of 4D T2*quantification in the lung with oxygen gas challenge in patients with non-small cell lung cancer.
Phys Med 72(): 46-51.

Salas-Ramirez M, Tran-Gia J, Gbureck U, Kosmala A, Lassmann M (2020)
Quantification of the trabecular bone volume fraction for bone marrow dosimetry in molecular radiotherapy by using a dual-energy (SPECT/)CT (vol 64, 205014, 2019).
Phys Med Biol 65(2).

Höhn F, Hammer S, Fellner C, Zeman F, Uller W, Brill R, Guntau M, Wildgruber M, Wohlgemuth WA (2020)
3T MRI of Peripheral Vascular Malformations: Characteristics and Comparison of Two Fat-Saturated sequences: Short Tau Inversion Recovery Versus Three-Dimensional High-Resolution Volume Interpolated Gradient Recalled Echo.
Rofo.

Janssen JP, Hoffmann JV, Kanno T, Nose N, Grunz JP, Onoguchi M, Chen XY, Lapa C, Buck AK, Higuchi T (2020)
Capabilities of multi-pinhole SPECT with two stationary detectors for in vivo rat imaging.
Sci Rep 10(1).

Werner RA, Derlin T, Lapa C, Sheikbahaei S, Higuchi T, Giesel FL, Behr S, Drzezga A, Kimura H, Buck AK, Bengel FM, Pomper MG, Gorin MA, Rowe SP (2020)
18F-Labeled, PSMA-Targeted Radiotracers: Leveraging the Advantages of Radiofluorination for Prostate Cancer Molecular Imaging.
Theranostics 10(1): 1-16.

Werner RA, Chen X, Rowe SP, Lapa C, Javadi MS, Higuchi T (2020)
Recent paradigm shifts in molecular cardiac imaging-Establishing precision cardiology through novel 18F-labeled PET radiotracers.
Trends Cardiovasc Med 30(1): 11-19.

Yonekura Y, Mattsson S, Flux G, Bolch WE, Dauer LT, Fisher DR, Lassmann M, Palm S, Hosono M, Doruff M, Divgi C, Zanzonico P (2019)
ICRP Publication 140: Radiological Protection in Therapy with Radiopharmaceuticals.
Ann ICRP 48(1): 5-95.

Sheikhbahaei S, Jones KM, Werner RA, Salas-Fragomeni RA, Marcus CV, Higuchi T, Rowe SP, Solnes LB, Javadi MS (2019)18F-NaF-PET/CT for the detection of bone metastasis in prostate cancer: a meta-analysis of diagnostic accuracy studies.
Ann Nucl Med 33(5): 351-361.

Brumberg J, Tran-Gia J, Lapa C, Isaias IU, Samnick S (2019)
PET imaging of noradrenaline transporters in Parkinson's disease: focus on scan time.
Ann Nucl Med 33(2): 69-77.

Lapa C, Lückerath K, Kircher S, Hänscheid H, Grigoleit GU, Rosenwald A, StolzenburgA, Kropf S, Einsele H, Wester HJ, Buck AK, Kortüm KM, Schirbel A (2019)
Potential influence of concomitant chemotherapy on CXCR4 expression in receptor directed endoradiotherapy.
Br J Haematol 184(3): 440-443.

Pozzi NG, Canessa A, Palmisano C, Brumberg J, Steigerwald F, Reich MM, Minafra B, Pacchetti C, Pezzoli G, Volkmann J, Isaias IU (2019)
Freezing of gait in Parkinson's disease reflects a sudden derangement of locomotor network dynamics.
Brain 142(): 2037-2050.

Scherthan H, Lee JH, Maus E, Schumann S, Muhtadi R, Chojowski R, Port M, Lassmann M, Bestvater F, Hausmann M (2019)
Nanostructure of Clustered DNA Damage in Leukocytes after In-Solution Irradiation with the Alpha Emitter Ra-223.
Cancers 11(12).

Kertels O, Mihovilovic MI, Linsenmann T, Kessler AF, Tran-Gia J, Kircher M, Brumberg J, Monoranu CM, Samnick S, Ernestus RI, Löhr M, Meyer PT, Lapa C (2019)
Clinical Utility of Different Approaches for Detection of Late Pseudoprogression in Glioblastoma With O-(2-[18F]Fluoroethyl)-L-Tyrosine PET.
Clin Nucl Med 44(9): 695-701.

Lapa C, Kircher M, Da Via M, Schreder M, Rasche L, Kortüm KM, Einsele H, Buck AK, Hänscheid H, Samnick S (2019)
Comparison of 11C-Choline and 11C-Methionine PET/CT in Multiple Myeloma.
Clin Nucl Med 44(8): 620-624.

Werner RA, Ordonez AA, Sanchez-Bautista J, Marcus C, Lapa C, Rowe SP, Pomper MG, Leal JP, Lodge MA, Javadi MS, Jain SK, Higuchi T (2019)
Novel Functional Renal PET Imaging With 18F-FDS in Human Subjects.
Clin Nucl Med 44(5): 410-411.

Werner RA, Marcus C, Sheikhbahaei S, Solnes LB, Leal JP, Du Y, Rowe SP, Higuchi T, Buck AK, Lapa C, Javadi MS (2019)
Visual and Semiquantitative Accuracy in Clinical Baseline 123I-Ioflupane SPECT/CT Imaging.
Clin Nucl Med 44(1): 1-3.

Beykan S, Fani M, Jensen SB, Nicolas G, Wild D, Kaufmann J, Lassmann M (2019)
In Vivo Biokinetics of 177Lu-OPS201 in Mice and Pigs as a Model for Predicting Human Dosimetry.
Contrast Media Mol Imaging 2019().

Brumberg J, Blazhenets G, Schröter N, Frings L, Jost WH, Lapa C, Meyer PT (2019)
Imaging cardiac sympathetic innervation with MIBG: linear conversion of the heart-to-mediastinum ratio between different collimators.
EJNMMI Phys 6(1).

Blautzik J, Grelich L, Schramm N, Henkel R, Bartenstein P, Pfluger T (2019)
What and how should we measure in paediatric oncology FDG-PET/CT? Comparison of commonly used SUV metrics for differentiation between paediatric tumours.
EJNMMI Res 9(1).

Werner RA, Bundschuh RA, Higuchi T, Javadi MS, Rowe SP, Zsótér N, Kroiss M, Fassnacht M, Buck AK, Kreissl MC, Lapa C (2019)
Volumetric and texture analysis of pretherapeutic F-FDG PET can predict overall survival in medullary thyroid cancer patients treated with Vandetanib.
Endocrine 63(2): 293-300.

Werner RA, Wakabayashi H, Bauer J, Schütz C, Zechmeister C, Hayakawa N, Javadi MS, Lapa C, Jahns R, Ergün S, Jahns V, Higuchi T (2019)
Longitudinal 18F-FDG PET imaging in a rat model of autoimmune myocarditis.
Eur Heart J Cardiovasc Imaging 20(4): 467-474.

Schumann S, Scherthan H, Lapa C, Serfling S, Muhtadi R, Lassmann M, Eberlein U (2019)
DNA damage in blood leucocytes of prostate cancer patients during therapy with 177Lu-PSMA.
Eur J Nucl Med Mol Imaging 46(8): 1723-1732.

Kircher M, Ihne S, Brumberg J, Morbach C, Knop S, Kortüm KM, Störk S, Buck AK, Reiter T, Bauer WR, Lapa C (2019)
Detection of cardiac amyloidosis with 18F-Florbetaben-PET/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy.
Eur J Nucl Med Mol Imaging 46(7): 1407-1416.

Kratochwil C, Fendler WP, Eiber M, Baum R, Bozkurt MF, Czernin J, Delgado Bolton RC, Ezziddin S, Forrer F, Hicks RJ, Hope TA, Kabasakal L, Konijnenberg M, Kopka K, Lassmann M, Mottaghy FM, Oyen W, Rahbar K, Schöder H, Virgolini I, Wester HJ, Bodei L, Fanti S, Haberkorn U, Herrmann K (2019)
EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT).
Eur J Nucl Med Mol Imaging 46(12): 2536-2544.

Eskian M, Alavi A, Khorasanizadeh M, Viglianti BL, Jacobsson H, Barwick TD, Meysamie A, Yi SK, Iwano S, Bybel B, Caobelli F, Lococo F, Gea J, Sancho-Muñoz A, Schildt J, Tatcı E, Lapa C, Keramida G, Peters M, Boktor RR, John J, Pitman AG, Mazurek T, Rezaei N (2019)
Effect of blood glucose level on standardized uptake value (SUV) in 18F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements.
Eur J Nucl Med Mol Imaging 46(1): 224-237.

Hartrampf PE, Seitz AK, Krebs M, Buck AK, Lapa C (2019)
False-negative 18F-PSMA-1007 PET/CT in metastatic prostate cancer related to high physiologic liver uptake.
Eur J Nucl Med Mol Imaging.

Werner RA, Chen X, Lapa C, Koshino K, Rowe SP, Pomper MG, Javadi MS, Higuchi T (2019)
The next era of renal radionuclide imaging: novel PET radiotracers.
Eur J Nucl Med Mol Imaging 2019; 46(9): 1773-1786.

Dierks A, Kircher M, Schmid SJ, Kramer D, Buck AK, Lapa C (2019)
Tiger man sign in sarcoid myopathy.
Eur J Nucl Med Mol Imaging 46(4): 1039-1040.

Werner RA, Kircher S, Higuchi T, Kircher M, Schirbel A, Wester HJ, Buck AK, Pomper MG, Rowe SP, Lapa C (2019)
CXCR4-Directed Imaging in Solid Tumors.
Front Oncol 9().

Breun M, Monoranu CM, Kessler AF, Matthies C, Löhr M, Hagemann C, Schirbel A, Rowe SP, Pomper MG, Buck AK, Wester HJ, Ernestus RI, Lapa C (2019)
[68Ga]-Pentixafor PET/CT for CXCR4-Mediated Imaging of Vestibular Schwannomas.
Front Oncol 9().

Werner RA, Chen X, Rowe SP, Lapa C, Javadi MS, Higuchi T (2019)
Moving into the next era of PET myocardial perfusion imaging: introduction of novel 18F-labeled tracers.
Int J Cardiovasc Imaging 35(3): 569-577.

Werner RA, Savoie B, Javadi MS, Pomper MG, Higuchi T, Lapa C, Rowe SP (2019)
From the Reading Room to the Courtroom-The Use of Molecular Radionuclide Imaging in Criminal Trials.
J Am Coll Radiol 16(11): 1612-1617.

Rieckmann M, Delgobo M, Gaal C, Büchner L, Steinau P, Reshef D, Gil-Cruz C, Horst ENT, Kircher M, Reiter T, Heinze KG, Niessen HW, Krijnen PA, van der Laan AM, Piek JJ, Koch C, Wester HJ, Lapa C, Bauer WR, Ludewig B, Friedman N, Frantz S, Hofmann U, Ramos GC (2019)
Myocardial infarction triggers cardioprotective antigen-specific T helper cell responses.
J Clin Invest 130(11): 4922-4936.

Yagi Y, Shimizu Y, Arimitsu K, Nakamoto Y, Higuchi T, Togashi K, Kimura H (2019)
Efficient gallium-68 radiolabeling reaction of DOTA derivatives using a resonant-type microwave reactor.
J Labelled Comp Radiopharm 62(3): 132-138.

Mihovilovic MI, Kertels O, Hänscheid H, Löhr M, Monoranu CM, Kleinlein I, Samnick S, Kessler AF, Linsenmann T, Ernestus RI, Buck AK, Lapa C (2019)
O-(2-(18F)fluoroethyl)-L-tyrosine PET for the differentiation of tumour recurrence from late pseudoprogression in glioblastoma.
J Neurol Neurosurg Psychiatry 90(2): 238-239.

Tran-Gia J, Lassmann M (2019)
Characterization of Noise and Resolution for Quantitative 177Lu SPECT/CT with xSPECT Quant.
J Nucl Med 60(1): 50-59.

Lapa C, Hänscheid H, Kircher M, Schirbel A, Wunderlich G, Werner RA, Samnick S, Kotzerke J, Einsele H, Buck AK, Wester HJ, Grigoleit GU (2019)
Feasibility of CXCR4-Directed Radioligand Therapy in Advanced Diffuse Large B-Cell Lymphoma.
J Nucl Med 60(1): 60-64.

Yin Y, Werner RA, Higuchi T, Lapa C, Pienta KJ, Pomper MG, Gorin MA, Rowe SP (2019)
Follow-up of Lesions with Equivocal Radiotracer Uptake on PSMA-Targeted PET in Patients with Prostate Cancer: Predictive Values of the PSMA-RADS-3A and PSMA-RADS-3B Categories.
J Nucl Med 60(4): 511-516.

Kircher S, Stolzenburg A, Kortuem KM, Kircher M, Da Via M, Samnick S, Buck A, Einsele H, Rosenwald A, Lapa C (2019)
Hexokinase-2 Expression in C-Methionine-Positive, F-FDG-Negative Multiple Myeloma.
J Nucl Med 60(3): 348-352.

Werner RA, Bundschuh RA, Bundschuh L, Fanti S, Javadi MS, Higuchi T, Weich A, Pienta KJ, Buck AK, Pomper MG, Gorin MA, Herrmann K, Lapa C, Rowe SP (2019)
Novel Structured Reporting Systems for Theranostic Radiotracers.
J Nucl Med 60(5): 577-584.

Maurer S, Herhaus P, Lippenmeyer R, Hänscheid H, Kircher M, Schirbel A, Maurer HC, Buck AK, Wester HJ, Einsele H, Grigoleit GU, Keller U, Lapa C (2019)
Side Effects of CXC-Chemokine Receptor 4-Directed Endoradiotherapy with Pentixather Before Hematopoietic Stem Cell Transplantation.
J Nucl Med 60(10): 1399-1405.

Treves ST, Gelfand M, Parisi M, Lassmann M, Goske M, Sexton-Stallone B, Fahey F (2019)
Update: Image Gently and Nuclear Medicine at 10 Years.
J Nucl Med 60(4): 7N-9N.

Mangelis A, Jühlen R, Dieterich P, Peitzsch M, Lenders JWM, Hahner S, Schirbel A, Eisenhofer G (2019)
A steady state system for in vitro evaluation of steroidogenic pathway dynamics: Application for CYP11B1, CYP11B2 and CYP17 inhibitors.
J Steroid Biochem Mol Biol 188(): 38-47.

Werner RA, Koshino K, Arimitsu K, Lapa C, Javadi MS, Rowe SP, Nose N, Kimura H, Fukushima K, Higuchi T (2019)
Stability of Distribution of F18 Flurpiridaz After Transient Coronary Occlusion in Pigs.
JACC Cardiovasc Imaging 12(11 Pt 1): 2269-2271.

Takahashi Y, Kioka H, Shintani Y, Ohki A, Takashima S, Sakata Y, Higuchi T, Saito S (2019)
Detection of increased intracerebral lactate in a mouse model of Leigh syndrome using proton MR spectroscopy.
Magn Reson Imaging 58(): 38-43.

Ohki A, Saito S, Hata J, Okano HJ, Higuchi T, Fukuchi K (2019)
Neurite orientation dispersion and density imaging for evaluating the severity of neonatal hypoxic-ischemic encephalopathy in rats.
Magn Reson Imaging 2019; 62(): 214-219.

Werner RA, Hänscheid H, Leal JP, Javadi MS, Higuchi T, Lodge MA, Buck AK, Pomper MG, Lapa C, Rowe SP (2019)
Impact of Tumor Burden on Quantitative [68Ga] DOTATOC Biodistribution.
Mol Imaging Biol 21(4): 790-798.

Werner RA, Ilhan H, Lehner S, Papp L, Zsótér N, Schatka I, Muegge DO, Javadi MS, Higuchi T, Buck AK, Bartenstein P, Bengel F, Essler M, Lapa C, Bundschuh RA (2019)
Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy.
Mol Imaging Biol 21(3): 582-590.

Kertels O, Kessler AF, Mihovilovic MI, Stolzenburg A, Linsenmann T, Samnick S, Brändlein S, Monoranu CM, Ernestus RI, Buck AK, Löhr M, Lapa C (2019)
Prognostic Value of O-(2-[18F]Fluoroethyl)-L-Tyrosine PET/CT in Newly Diagnosed WHO 2016 Grade II and III Glioma.
Mol Imaging Biol 21(6): 1174-1181.

Werner RA, Lapa C, Sheikhbahaei S, Marcus C, Solnes LB, Du Y, Leal JP, Buck AK, Higuchi T, Rowe SP, Javadi MS (2019)
Impact of aging on semiquantitative uptake parameters in normal rated clinical baseline [123I]Ioflupane single photon emission computed tomography/computed tomography.
Nucl Med Commun 40(10): 1001-1004.

Farahati J, Mäder U, Gilman E, Görges R, Maric I, Binse I, Hänscheid H, Herrmann K, Buck A, Bockisch A (2019)
Changing trends of incidence and prognosis of thyroid carcinoma.
Nuklearmedizin 58(2): 86-92.

Kircher M, Seifert S, Kircher S, Lapa C (2019)
[99mTc]Tilmanocept Lymphscintigraphy after inconclusive [99mTc]Nanocolloid Scan in Breast Cancer.
Nuklearmedizin 2019; 58(3): 282-284.

Verburg FA, Schmidt M, Kreissl MC, Grünwald F, Lassmann M, Hänscheid H, Hohberg M, Luster M, Dietlein M (2019)
[Procedural guideline for Iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma (version 5)].
Nuklearmedizin 58(3): 228-241.

Da Via MC, Solimando AG, Garitano-Trojaola A, Barrio S, Munawar U, Strifler S, Haertle L, Rhodes N, Teufel E, Vogt C, Lapa C, Beilhack A, Rasche L, Einsele H, Kortüm KM (2019)
CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAFMEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System Involvement.
Oncologist.

Salas-Ramirez M, Tran-Gia J, Gbureck U, Kosmala A, Lassmann M (2019)
Quantification of the trabecular bone volume fraction for bone marrow dosimetry in molecular radiotherapy by using a dual-energy (SPECT/)CT.
Phys Med Biol 64(20).

Giovanella L, Lassmann M (2019)
Radioiodine dosimetry in advanced thyroid cancer.
Q J Nucl Med Mol Imaging 63(3): 227-228.

Werner RA, Wakabayashi H, Chen X, Hayakawa N, Lapa C, Rowe SP, Javadi MS, Robinson S, Higuchi T (2019)
Ventricular Distribution Pattern of the Novel Sympathetic Nerve PET Radiotracer 18F-LMI1195 in Rabbit Hearts.
Sci Rep 9(1).

Sheikhbahaei S, Werner RA, Solnes LB, Pienta KJ, Pomper MG, Gorin MA, Rowe SP (2019)
Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer: An Update on Important Pitfalls.
Semin Nucl Med 49(4): 255-270.

Rasche L, Kumar M, Gershner G, Samant R, Van Hemert R, Heidemeier A, Lapa C, Bley T, Buck A, McDonald J, Hillengass J, Epstein J, Thanendrarajan S, Schinke C, van Rhee F, Zangari M, Barlogie B, Davies FE, Morgan GJ, Weinhold N (2019)
Lack of Spleen Signal on Diffusion Weighted MRI is associated with High Tumor Burden and Poor Prognosis in Multiple Myeloma: A Link to Extramedullary Hematopoiesis?
Theranostics 9(16): 4756-4763.

Diehl-Schmid J, Licata A, Goldhardt O, Förstl H, Yakushew I, Otto M, Anderl-Straub S, Beer A, Ludolph AC, Landwehrmeyer GB, Levin J, Danek A, Fliessbach K, Spottke A, Fassbender K, Lyros E, Prudlo J, Krause BJ, Volk A, Edbauer D, Schroeter ML, Drzezga A, Kornhuber J, Lauer M, FTLDc study group, Grimmer T (2019)
FDG-PET underscores the key role of the thalamus in frontotemporal lobar degeneration caused by C9ORF72 mutations.
Transl Psychiatry 9(1).

Hofmann C, Girschick H, Lapa C, Semler O, Jakob F (2019)
[Fractures and bone mineral density in childhood].
Z Rheumatol 78(7): 636-644.

Arnulfo G, Pozzi NG, Palmisano C, Leporini A, Canessa A, Brumberg J, Pezzoli G, Matthies C, Volkmann J, Isaias IU (2018)
Phase matters: A role for the subthalamic network during gait.
PLoS ONE 13(6).

Bauer WR, Lapa C, Reiter T (2018)
It's the Metabolism That Makes Macrophages Detectable in the Magnetic Resonance Scanner Immune Cell Detection by Hyperpolarized C-13 Magnetic Resonance Imaging.
Circ Res 122(8): 1039-1040.

Berninger M, Erk C, Fuss A, Skaf J, Al-Momani E, Israel I, Raschig M, Guentzel P, Samnick S, Holzgrabe U (2018)
Fluorine walk: The impact of fluorine in quinolone amides on their activity against African sleeping sickness.
Eur J Med Chem 152(): 377-391.

Beukhof CM, Massolt ET, Visser TJ, Korevaar TIM, Medici M, de Herder WW, van Lennep JER, Mulder MT, de Rijke YB, Reiners C, Verburg FA, Peeters RP (2018)
Effects of Thyrotropin on Peripheral Thyroid Hormone Metabolism and Serum Lipids.
Thyroid 28(2): 168-174.

Beykan S, Eberlein U, Werner RA, Lapa C, Buck AK, Kudlich T, Lassmann M (2018)
Patient-Specific Dosimetry of Lu-177-DOTATATE Peptide Receptor Radionuclide Therapy with High Activities.
Eur J Nucl Med Mol Imaging 45 1(): S33-S33 Typ=Meeting Abstract.

Brumberg J, Isaias IU (2018)
SPECT Molecular Imaging in Atypical Parkinsonism.
Int Rev Neurobiol 142(): 37-65.

Chen XY, Hirano M, Werner RA, Decker M, Higuchi T (2018)
Novel F-18-Labeled PET Imaging Agent FV45 Targeting the Renin-Angiotensin System.
ACS Omega 3(9): 10460-10470.

Chen XY, Werner RA, Lapa C, Nose N, Hirano M, Javadi MS, Robinson S, Higuchi T (2018)
Subcellular storage and release mode of the novel F-18-labeled sympathetic nerve PET tracer.
LMI1195 EJNMMI Res 8().

Cytawa W, Kircher S, Schirbel A, Shirai T, Fukushima K, Buck AK, Wester HJ, Lapa C (2018)
Chemokine Receptor 4 Expression in Primary Sjögren's Syndrome.
Clin Nucl Med 43(11): 835-836 Typ=Case Reports;Journal Article.

Da Via MC, Solimando AG, Garitano-Trojaola A, Barrio S, Rodhes N, Strifler S, Teufel E, Lapa C, Einsele H, Beilhack A, Kortuem KM (2018)
CIC-Mutation As a Potential Molecular Mechanism of Acquired Resistance to Combined BRAF/MEK Inhibition.
CNS Multiple Myeloma Blood 132(): Typ=Meeting Abstract.

Da Via MC, Trojaola AG, Solimando AG, Barrio SG, Teufel E, Einsele H, Lapa C, Beilhack A, Kortum MK (2018)
CIC-mutation as a potential molecular mechanism of acquired resistance to combined BRAF/MEK Inhibition.
CNS MM localization Oncology Research and Treatment 41 4(): 187-187 Typ=Meeting Abstract.

Duell J, Rosenwald A, Krummenast F, Buck A, Einsele H, Topp MS, Lapa C (2018)
CXCR4 PET/CT Scan Is Superior to FDG PET/CT Scan.
Accurately Defining Marginal Zone Lymphoma Nodal and Extranodal Blood 132(): Typ=Meeting Abstract.

Drozd VM, Branovan I, Shiglik N, Biko J, Reiners C (2018)
Thyroid Cancer Induction: Nitrates as Independent Risk Factors or Risk Modulators after Radiation Exposure, with a Focus on the Chernobyl Accident.
Eur Thyroid J 7(2): 67-74.

Flux GD, Gleisner KS, Chiesa C, Lassmann M, Chouin N, Gear J, Bardies M, Walrand S, Bacher K, Eberlein U, Ljungberg M, Strigari L, Visser E, Konijnenberg MW (2018)
From fixed activities to personalized treatments in radionuclide therapy: lost in translation?
Eur J Nucl Med Mol Imaging 45(1): 152-154.

Habringer S, Lapa C, Herhaus P, Schottelius M, Istvánffy R, Steiger K, Slotta-Huspenina J, Schirbel A, Hänscheid H, Kircher S, Buck AK, Götze K, Vick B, Jeremias I, Schwaiger M, Peschel C, Oostendorp R, Wester HJ, Grigoleit GU, Keller U (2018)
Dual Targeting of Acute Leukemia and Supporting Niche by CXCR4-Directed Theranostics.
Theranostics 8(2): 369-383 Typ=Journal Article.

Hänscheid H, Lapa C, Buck AK, Lassmann M, Werner RA (2018)
Dose Mapping After Endoradiotherapy with Lu-DOTATATE/DOTATOC by a Single Measurement After 4 Days.
J Nucl Med 59(1): 75-81 Typ=Journal Article.

Heinze B, Fuss CT, Mulatero P, Beuschlein F, Reincke M, Mustafa M, Schirbel A, Deutschbein T, Williams TA, Rhayem Y, Quinkler M, Rayes N, Monticone S, Wild V, Gomez-Sanchez CE, Reis AC, Petersenn S, Wester HJ, Kropf S, Fassnacht M, Lang K, Herrmann K, Buck AK, Bluemel C, Hahner S (2018)
Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma.
Hypertension 71(2): 317-325 Typ=Journal Article.

Herhaus P, Maurer S, Lippenmayer R, Meys D, Schwaiger M, Buck A, Einsele H, Grigoleit GU, Keller U, Lapa C (2018)
Safety and toxicity of CXCR4-directed endoradiotherapy with Pentixather in hematologic malignancies: a retrospective analysis.
Oncology Research and Treatment 41 4(): 155-155 Typ=Meeting Abstract.

Israel I, Fluri F, Schadt F, Buck AK, Samnick S (2018)
Positron Emission Tomography and Autoradiography Imaging of P-selectin Activation Using Ga-68-Fucoidan in Photothrombotic Stroke Curr Neurovasc Res 15(1): 55-62.

Kertels O, Stolzenburg A, Mihovilovic M, Kessler A, Samnick S, Monoranu C, Löhr M, Buck A, Lapa C (2018)
[F-18]FET-PET/CT as a prognostic factor in newly-diagnosed gliomas II and III.
J Nucl Med 59(): Typ=Meeting Abstract.

Kircher M, Herhaus P, Schottelius M, Buck AK, Werner RA, Wester HJ, Keller U, Lapa C (2018)
CXCR4-directed theranostics in oncology and inflammation.
Ann Nucl Med 32(8): 503-511.

Lamparter D, Hallmann B, Haenscheid H, Boschi F, Malinconico M, Samnick S (2018)
Improved small scale production of iodine-124 for radiolabeling and clinical applications.
Appl Radiat Isot 140(): 24-28.

Lapa C, Kircher M, Hänscheid H, Schirbel A, Grigoleit GU, Klinker E, Böck M, Samnick S, Pelzer T, Buck AK (2018)
Peptide receptor radionuclide therapy as a new tool in treatment-refractory sarcoidosis - initial experience in two patients.
Theranostics 8(3): 644-649 Typ=Journal Article;Research Support, Non-U.S. Gov't.

Lapa C, Schreder M, Lückerath K, Samnick S, Rudelius M, Buck AK, Kortüm KM, Einsele H, Rosenwald A, Knop S (2018)
[C]Methionine emerges as a new biomarker for tracking active myeloma lesions.
Br J Haematol 181(5): 701-703 Typ=Letter.

Lassmann M, Eberlein U (2018)
The Relevance of Dosimetry in Precision Medicine.
J Nucl Med 2018; 59(10): 1494-1499.

Lassmann M, Eberlein U (2018)
Targeted alpha-particle therapy: imaging, dosimetry, and radiation protection.
Ann ICRP 47(3-4): 187-195 Typ=Journal Article.

Leek F, Gregory R, Newbold K, Verburg FA, Luster M, Schurrat T, Lassmann M, Eberlein U, Buck AK, Lapa C, Bardies M, Mora-Ramirez E, Vallot D, Courbon F, Vija L, Flux G (2018)
The MEDIRAD Multi-national I-131 Dosimetry Study for Thyroid Ablation and Adjuvant Therapy
Eur J Nucl Med Mol Imaging 45(): S359-S360 Typ=Meeting Abstract.

Li X, Kemmer L, Zhang XL, Kircher M, Buck AK, Wester HJ, Hacker M, Lapa C (2018)
Anti-Inflammatory Effects on Atherosclerotic Lesions Induced by CXCR4-Directed Endoradiotherapy
J Am Coll Cardiol 72(1): 122-123.

Lisova K, Sergeev M, Evans-Axelsson S, Stuparu AD, Beykan S, Collins J, Jones J, Lassmann M, Herrmann K, Perrin D, Lee JT, Slavik R, van Dam RM (2018)
Microscale radiosynthesis, preclinical imaging and dosimetry study of [F-18]AMBF(3)-TATE: A potential PET tracer for clinical imaging of somatostatin receptors
Nucl Med Biol 61(): 36-44.

Machado JS, Tran-Gia J, Schloegl S, Buck A, Lassmann M (2018)
Biokinetics, dosimetry, and radiation risk in infants after Tc-99m-MAG3 scans
EJNMMI Res 8().

Marienhagen J, Brenner W, Buck A, Franzius C, Freudenberg LS, Gotthardt M, Lindner O, Mottaghy FM, Hellwig D (2018)
[Development of a national competency-based learning objective catalogue for undergraduate medical education in Germany].
Nuklearmedizin 57(4): 137-145 Typ=Journal Article.

Matsuura S, Katsumi H, Suzuki H, Hirai N, Hayashi H, Koshino K, Higuchi T, Yagi Y, Kimura H, Sakane T, Yamamoto A (2018)
L-Serine-modified polyamidoamine dendrimer as a highly potent renal targeting drug carrier
Proc Natl Acad Sci U S A 115(41): 10511-10516.

Meyerhof W, Voigt A, Huebner S, Lossow K, Toele J, Stolzenburg A, Brockhoff A, Blank K, Boehm U, Behrens M (2018)
The complex basis of bitterness perception Chem Senses 43(3): E2-E2 Typ=Meeting Abstract.

Neba J, Wuestemann J, Matthies P, Pinto F, Barthel T, Schwenkenbecher K, Grosser O, Lassmann M (2018)
Relevant Specific Simulation Parameters (ReSSiP) for validating the "true" device-simulated outcomes: A Handheld Gamma Camera System
Eur J Nucl Med Mol Imaging 45(): S781-S782 Typ=Meeting Abstract.

Nicolas GP, Beykan S, Bouterfa H, Kaufmann J, Bauman A, Lassmann M, Reubi JC, Rivier JEF, Maecke HR, Fani M, Wild D (2018)
Safety, Biodistribution, and Radiation Dosimetry of Ga-68-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study
J Nucl Med 59(6): 909-914.

Nicolas G, Bodei L, Baum R, Herrmann K, Lassmann M, Hicks R, Navalkissoor S, Haug A, Oberwittler H, Wang T, Wild D (2018)
Phase 1/2 Open-Label Trial to Assess the Safety and Preliminary Efficacy of Lu-177-OPS201 as Peptide Receptor Radionuclide Therapy in Patients With Somatostatin Receptor-Positive, Progressive Neuroendocrine Tumors Pancreas 47(3): 349-349 Typ=Meeting Abstract.

Nose N, Werner RA, Ueda Y, Guenther K, Lapa C, Javadi MS, Fukushima K, Edenhofer F, Higuchi T (2018)
Metabolic substrate shift in human induced pluripotent stem cells during cardiac differentiation: Functional assessment using in vitro radionuclide uptake assay
Int J Cardiol 269(): 229-234.

Palmisano C, Brandt G, Pozzi NG, Brumberg J, Leporini A, Marotta G, Cavallari P, Frigo CA, Pezzoli G, Isaias IU (2018)
A SELECTIVE ROLE OF STRIATAL DOPAMINE IN THE TIMING OF ANTICIPATORY POSTURAL ADJUSTMENTS AT GAIT INITIATION IN PATIENTS WITH PARKINSON'S DISEASE
Parkinsonism Relat Disord 46(): E76-E77 Typ=Meeting Abstract.

Reiter T, Kircher M, Schirbel A, Werner RA, Kropf S, Ertl G, Buck AK, Wester HJ, Bauer WR, Lapa C (2018)
Imaging of C-X-C Motif Chemokine Receptor CXCR4 Expression After Myocardial Infarction With [Ga-68] Pentixafor-PET/CT in Correlation With Cardiac MRI JACC Cardiovasc Imaging 11(10): 1541-1543.

Samnick S, Al-Momani E, Schmid JS, Mottok A, Buck AK, Lapa C (2018)
Initial Clinical Investigation of [18F]Tetrafluoroborate PET/CT in Comparison to [124I]Iodine PET/CT for Imaging Thyroid Cancer
Clin Nucl Med 43(3): 162-167.

Salas-Ramirez M, Tran-Gia J, Kesenheimer C, Weng AM, Kosmala A, Heidemeier A, Köstler H, Lassmann M (2018)
Quantification of fat fraction in lumbar vertebrae: correlation with age and implications for bone marrow dosimetry in molecular radiotherapy.
Phys Med Biol 63(2): 025029 Typ=Journal Article;Research Support, Non-U.S. Gov't.

Salas-Ramirez M, van Rietbergen B, Lassmann M (2018)
Prototype for a Mesh-based Radiation Transport Model for Bone Marrow Dosimetry using GATE
Eur J Nucl Med Mol Imaging 45(): S181-S182 Typ=Meeting Abstract.

Schumann S, Eberlein U, Mueller J, Lassmann M, Scherthan H (2018)
Absorbed dose-dependent DNA damage in leukocytes after internal irradiation of blood with Ra-224 compared to Ra-223
Eur J Nucl Med Mol Imaging 45(): S121-S122 Typ=Meeting Abstract.

Schumann S, Eberlein U, Muhtadi R, Lassmann M, Scherthan H (2018)
DNA damage in leukocytes after internal ex-vivo irradiation of blood with the alpha-emitter Ra-223
Sci Rep 8().

Schumann S, Eberlein U, Mueller J, Scherthan H, Lassmann M (2018)
Correlation of the absorbed dose to the blood and DNA damage in leukocytes after internal ex-vivo irradiation of blood samples with Ra-224
EJNMMI Res 8().

Selcuk NA, Toklu T, Beykan S, Karaaslan SI (2018)
Evaluation of the dosimetry approaches in ablation treatment of thyroid cancer
J. Appl. Clin. Med. Phys 19(4): 134-140.

Stolzenburg A, Lückerath K, Samnick S, Speer M, Kneer K, Schmid JS, Grigoleit GU, Hofmann S, Beer AJ, Bunjes D, Knop S, Buck AK, Einsele H, Lapa C (2018)
Prognostic value of [F]FDG-PET/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantation.
Eur J Nucl Med Mol Imaging 45(10): 1694-1704 Typ=Journal Article.

Solimando AG, Da Via MC, Borrelli P, Leone P, Di Lernia G, Gaviria PT, Brandl A, Pedone GL, Rauert-Wunderlich H, Lapa C, Tafuri S, Bianchi FP, Ria R, Bittrich M, Ribatti D, Rosenwald A, Kortuem KM, Racanelli V, Vacca A, Einsele H, Beilhack A (2018)
Central Function for JAM-a in Multiple Myeloma Patients with Extramedullary Disease
Blood 132(): Typ=Meeting Abstract.

Toele J, Stolzenburg A, Tyree SM, Staehler F, Meyerhof W (2018)
Tastant-Evoked Arc Expression in the Nucleus of the Solitary Tract and Nodose/Petrosal Ganglion of the Mouse Is Specific for Bitter Compounds
Chem Senses 43(4): 261-272.

Togawa K, Ahn HS, Auvinen A, Bauer AJ, Brito JP, Davies L, Kesminiene A, Laurier D, Ostroumova E, Pacini F, Reiners C, Shinkarev S, Thomas G, Tronko M, Vaccarella S, Schüz J (2018)
Long-term strategies for thyroid health monitoring after nuclear accidents: recommendations from an Expert Group convened by IARC Lancet Oncol 19(10): 1280-1283.

Tran-Gia J, Lassmann M (2018)
How Partial-Volume Effects Influence SPECT/CT-Based Organ Dose Estimates
Eur J Nucl Med Mol Imaging 45(): S182-S182 Typ=Meeting Abstract.

Tran-Gia J, Lassmann M (2018)
Optimizing Image Quantification for Lu-177 SPECT/CT Based on a 3D Printed 2-Compartment Kidney Phantom.
J Nucl Med 59(4): 616-624.

Tran-Gia J, Neumayer H, Lassmann M (2018)
On the Quantitative Accuracy of xSPECT Quant Based Renal Uptake Determination for Internal Dosimetry in Lu-177-PSMA Radioligand Therapy.
J Nucl Med 59(): Typ=Meeting Abstract.

Verburg FA, Gruenwald F, Lassmann M, Haenscheid H, Luster M, Dietlein M (2018)
Iodine-131 whole-body scintigraphy differentiated thyroid carcinoma.
Nuklearmedizin 57(4): 124-136.

Verburg FA, Giovanella L, Iakovou I, Konijnenberg MW, Langsteger W, Lassmann M, Mihailovic J, Luster M (2018)
I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an "inconvenient" truth?
Eur J Nucl Med Mol Imaging 45(13): 2247-2249.

Verburg FA, Mäder U, Giovanella L, Luster M, Reiners C (2018)
Low or Undetectable Basal Thyroglobulin Levels Obviate the Need for Neck Ultrasound in Differentiated Thyroid Cancer Patients After Total Thyroidectomy and I Ablation.
Thyroid 28(6): 722-728 Typ=Journal Article.

Verburg FA, Mäder U, Luster M, Reiners C (2018)
The effects of the Union for International Cancer Control/American Joint Committee on Cancer Tumour, Node, Metastasis system version 8 on staging of differentiated thyroid cancer: a comparison to version 7.
Clin Endocrinol (Oxf) 88(6): 950-956 Typ=Journal Article.

Wech T, Tran-Gia J, Rützel F, Klink T, Bley TA, Köstler H (2018)
Single-shot late Gd enhancement imaging of myocardial infarction with retrospectively adjustable contrast and heart-phase.
Magn Reson Imaging 47(): 48-53 Typ=Journal Article.

Werner RA, Andree C, Javadi MS, Lapa C, Buck AK, Higuchi T, Pomper MG, Gorin MA, Rowe SP, Pienta KJ (2018)
A Voice From the Past: Rediscovering the Virchow Node With Prostate-specific Membrane Antigen-targeted F-18-DCFPyL Positron Emission Tomography Imaging
Urology 117(): 18-21 Typ.

Werner RA, Bundschuh RA, Bundschuh L, Javadi MS, Higuchi T, Weich A, Sheikhbahaei S, Pienta KJ, Buck AK, Pomper MG, Gorin MA, Lapa C, Rowe SP (2018)
Molecular imaging reporting and data systems (MI-RADS): a generalizable framework for targeted radiotracers with theranostic implications.
Ann Nucl Med 32(8): 512-522 Typ=Journal Article;Review.

Werner RA, Bundschuh RA, Bundschuh L, Javadi MS, Leal JP, Higuchi T, Pienta KJ, Buck AK, Pomper MG, Gorin MA, Lapa C, Rowe SP (2018)
Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on F-18-DCFPyL PET/CT Imaging
J Nucl Med 59(12): 1857-1864.

Werner R, Bundschuh R, Higuchi T, Javadi M, Rowe S, Zsoter N, Buck A, Lapa C, Kreissl M (2018)
Volumetric Assessment Based On Baseline FDG PET Can Predict Survival In Medullary Thyroid Cancer Patients Scheduled For Vandetanib Treatment
Eur J Nucl Med Mol Imaging 45(): S49-S50 Typ=Meeting Abstract.

Werner R, Chen XY, Hirano M, Nose N, Lapa C, Javadi M, Higuchi T (2018)
The Impact of Ageing on [C-11]meta-Hydroxyephedrine Uptake in the Rat Heart
J Nucl Med 2018; 59().

Werner RA, Chen XY, Maya Y, Eissler C, Hirano M, Nose N, Wakabayashi H, Lapa C, Javadi MS, Higuchi T (2018)
The Impact of Ageing on 11C-Hydroxyephedrine Uptake in the Rat Heart Sci Rep 8().

Werner RA, Eissler C, Hayakawa N, Arias-Loza P, Wakabayashi H, Javadi MS, Chen XY, Shinaji T, Lapa C, Pelzer T, Higuchi T (2018)
Left Ventricular Diastolic Dysfunction in a Rat Model of Diabetic Cardiomyopathy using ECG-gated F-18-FDG PET Sci Rep 8().

Werner RA, Ilhan H, Lehner S, Papp L, Zsótér N, Schatka I, Muegge DO, Javadi MS, Higuchi T, Buck AK, Bartenstein P, Bengel F, Essler M, Lapa C, Bundschuh RA (2018)
Correction to: Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy.
Mol Imaging Biol 20(6): 1068 Typ=Journal Article;PUBLISHED ERRATUM.

Werner RA, Kobayashi R, Javadi MS, Koeck Z, Wakabayashi H, Unterecker S, Nakajima K, Lapa C, Menke A, Higuchi T (2018)
Impact of Novel Antidepressants on Cardiac I-123-Metaiodobenzylguanidine Uptake: Experimental Studies on SK-N-SH Cells and Healthy Rabbits
J Nucl Med 59(7): 1099-1103.

Werner R, Marcus C, Sheikhbahaei S, Higuchi T, Solnes L, Rowe S, Buck A, Lapa C, Javadi M (2018)
The Impact of Ageing on Dopamine Transporter Imaging
J Nucl Med 59(): Typ=Meeting Abstract.

Werner R, Marcus C, Sheikhbahaei S, Higuchi T, Solnes L, Rowe S, Bucks A, Lapa C, Javadi M (2018)
Diagnostic Accuracy of Visual Assessment of an Initial DaT-Scan in Comparison to a Fully AutomaticSemiquantitative Method
J Nucl Med 59(): Typ=Meeting Abstract.

Werner RA, Schmid JS, Higuchi T, Javadi MS, Rowe SP, Märkl B, Aulmann C, Fassnacht M, Kroiss M, Reiners C, Buck AK, Kreissl M, Lapa C (2018)
Predictive Value of F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib.
J Nucl Med 59(5): 756-761 Typ=Journal Article.

Werner RA, Solnes LB, Javadi MS, Weich A, Gorin MA, Pienta KJ, Higuchi T, Buck AK, Pomper MG, Rowe SP, Lapa C (2018)
SSTR-RADS Version 1.0 as a Reporting System for SSTR PET Imaging and Selection of Potential PRRT Candidates: A Proposed Standardization Framework.
J Nucl Med 59(7): 1085-1091 Typ=Journal Article.

Werner RA, Wakabayashi H, Chen X, Hirano M, Shinaji T, Lapa C, Rowe SP, Javadi MS, Higuchi T (2018)
Functional Renal Imaging with 2-Deoxy-2-F-Fluorosorbitol PET in Rat Models of Renal Disorders.
J Nucl Med 59(5): 828-832 Typ=Journal Article.

Werner RA, Weich A, Kircher M, Solnes LB, Javadi MS, Higuchi T, Buck AK, Pomper MG, Rowe SP, Lapa C (2018)
The theranostic promise for Neuroendocrine Tumors in the late 2010s-Where do we stand, where do we go?
Theranostics 8(22): 6088-6100.

Wevrett J, Fenwick A, Scuffham J, Johansson L, Gear J, Schlögl S, Segbers M, Sjögreen-Gleisner K, Solny P, Lassmann M, Tipping J, Nisbet A (2018)
Inter-comparison of quantitative imaging of lutetium-177 (Lu-177) in European hospitals EJNMMI Phys 5().

Wieder H, Beer AJ, Siveke J, Schuster T, Buck AK, Herrmann K, Stollfuss JC (2018)
18F-fluorothymidine PET for predicting survival in patients with resectable pancreatic cancer.
Oncotarget 9(11): 10128-10134 Typ=Journal Article.

Wöckel A, Festl J, Stüber T, Brust K, Krockenberger M, Heuschmann PU, Jírů-Hillmann S, Albert US, Budach W, Follmann M, Janni W, Kopp I, Kreienberg R, Kühn T, Langer T, Nothacker M, Scharl A, Schreer I, Link H, Engel J, Fehm T, Weis J, Welt A, Steckelberg A, Feyer P, König K, Hahne A, Baumgartner T, Kreipe HH, Knoefel WT, Denkinger M,
Brucker S, Lüftner D, Kubisch C, Gerlach C, Lebeau A, Siedentopf F, Petersen C, Bartsch HH, Schulz-Wendtland R, Hahn M, Hanf V, Müller-Schimpfle M, Henscher U, Roncarati R, Katalinic A, Heitmann C, Honegger C, Paradies K, Bjelic-Radisic V, Degenhardt F, Wenz F, Rick O, Hölzel D, Zaiss M, Kemper G, Budach V, Denkert C, Gerber B, Tesch H, Hirsmüller S, Sinn HP, Dunst J, Münstedt K, Bick U, Fallenberg E, Tholen R, Hung R, Baumann F, Beckmann MW, Blohmer J, Fasching P, Lux MP, Harbeck N, Hadji P, Hauner H, Heywang-Köbrunner S, Huober J, Hübner J, Jackisch C, Loibl S, Lück HJ, von Minckwitz G, Möbus V, Müller V, Nöthlings U, Schmidt M, Schmutzler R, Schneeweiss A, Schütz F, Stickeler E, Thomssen C, Untch M, Wesselmann S, Bücker A, Buck A, Stangl S (2018)
Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer.
Geburtsh Frauenheilk 78(11): 1056-1088 Typ=Journal Article.

Wuestemann J, Pinto FA, Mesri M, Matthies P, Neba JC, Pech M, Kreissl MC, Lassmann M, Grosser OS (2018)
Interventional Real-Time Quantification of Y-90-Microspheres Distribution in Selective Internal Radiotherapy
Eur J Nucl Med Mol Imaging 45(): S167-S168 Typ=Meeting Abstract.

Xu L, Tetteh G, Lipkova J, Zhao Y, Li HW, Christ P, Piraud M, Buck A, Shi KY, Menze BH (2018)
Automated Whole-Body Bone Lesion Detection for Multiple Myeloma on Ga-68-Pentixafor PET/CT Imaging Using Deep Learning Methods Contrast Media Mol Imaging.

Al-Momani E, Israel I, Samnick S (2017)
Validation of a [AlF]PSMA-11 preparation for clinical applications.
Appl Radiat Isot. 130: 102-108 (Impact(2016)=1.128, Typ=Journal Article).

Barquero R, Garcia HP, Incio MG, Minguez P, Cardenas A, Martínez D, Lassmann M (2017)
I activity quantification of gamma camera planar images.
Phys Med Biol. 62(3): 909-926 (Impact(2016)=2.742, Typ=Journal Article; Research Support, Non-U.S. Gov't).

Barrio MJ, Spick C, Radu CG, Lassmann M, Eberlein U, Allen-Auerbach M, Schiepers C, Slavik R, Czernin J, Herrmann K (2017)
Human Biodistribution and Radiation Dosimetry of F-Clofarabine, a PET Probe Targeting the Deoxyribonucleoside Salvage Pathway.
J Nucl Med. 58(3): 374-378 (Impact(2016)=6.646, Typ=Journal Article).

Bieber M, Werner RA, Tanai E, Hofmann U, Higuchi T, Schuh K, Heuschmann PU, Frantz S, Ritter O, Kraft P, Kleinschnitz C (2017)
Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted F-DCFPyL in peripheral ganglia.
Ann Nucl Med. 31(9): 696-702 (Impact(2016)=1.396, Typ=Journal Article).

Bluemel C, Hahner S, Heinze B, Fassnacht M, Kroiss M, Bley TA, Wester HJ, Kropf S, Lapa C, Schirbel A, Buck AK, Herrmann K (2017)
Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer Patients.
Clin Nucl Med. 42(1): e29-e34 (Impact(2016)=3.64, Typ=Article; Journal Article).

Bowles H, Sánchez N, Tapias A, Paredes P, Campos F, Bluemel C, Valdés Olmos RA, Vidal-Sicart S (2017)
Radioguided surgery and the GOSTT concept: From pre-operative image and intraoperative navigation to image-assisted excision. Rev Esp Med Nucl Imagen Mol. 36(3): 175-184 (Impact: liegt nicht vor, Typ=Journal Article).

Brumberg J, Küsters S, Al-Momani E, Marotta G, Cosgrove KP, van Dyck CH, Herrmann K, Homola GA, Pezzoli G, Buck AK, Volkmann J, Samnick S, Isaias IU (2017)
Cholinergic activity and levodopa-induced dyskinesia: a multitracer molecular imaging study.
Ann Clin Transl Neurol. 4(9): 632-639 (Impact: liegt nicht vor, Typ=Article; Journal Article).

Buck AK, Stolzenburg A, Hänscheid H, Schirbel A, Lückerath K, Schottelius M, Wester HJ, Lapa C (2017)
Chemokine receptor - Directed imaging and therapy.
Methods. 2017;130: 63-71 (Impact(2016)=3.802, Typ=Journal Article; Review).

Chiesa C, Sjogreen Gleisner K, Flux G, Gear J, Walrand S, Bacher K, Eberlein U, Visser EP, Chouin N, Ljungberg M, Bardiès M, Lassmann M, Strigari L, Konijnenberg MW (2017)
The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy.
Eur J Nucl Med Mol Imaging. 44(11): 1783-1786 (Impact(2016)=7.277, Typ=Editorial).

Doppler K, Jentschke HM, Schulmeyer L, Vadasz D, Janzen A, Luster M, Höffken H, Mayer G, Brumberg J, Booij J, Musacchio T, Klebe S, Sittig-Wiegand E, Volkmann J, Sommer C, Oertel WH (2017)
Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
Acta Neuropathol (Berl). 133(4): 535-545 (Impact(2016)=12.213, Typ=Journal Article).

Eberlein U, Cremonesi M, Lassmann M (2017)
Individualized Dosimetry for Theranostics: Necessary, Nice to Have, or Counterproductive?
J Nucl Med. 58(Suppl 2): 97S-103S (Impact(2016)=6.646, Typ=Journal Article; Review).

Fendler WP, Barrio M, Spick C, Allen-Auerbach M, Ambrosini V, Benz M, Bluemel C, Grewal RK, Lapa C, Miederer M, Nicolas G, Schuster T, Czernin J, Herrmann K (2017)
Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective Study.
J Nucl Med. 58(10): 1617-1623 (Impact(2016)=6.646, Typ=Journal Article; Clinical Trial; Multicenter Study).

Flux GD, Verburg FA, Chiesa C, Bardiès M, Gleisner KS, Hertz B, Konijnenberg M, Lassmann M, Ljungberg M, Luster M, Stabin M, Strigari L (2017)
Comparison of Empiric Versus Dosimetry-Guided Radioiodine Therapy: The Devil Is in the Details. J Nucl Med. 58(5): 862 (Impact(2016)=6.646, Typ=Letter).

Hayakawa N, Yamane T, Arias-Loza AP, Shinaji T, Wakabayashi H, Lapa C, Werner RA, Javadi MS, Pelzer T, Higuchi T (2017)
Impact of tissue photon attenuation in small animal cardiac PET imaging.
Int J Cardiol. 227: 257-260 (Impact(2016)=6.189, Typ=Journal Article).

Hänscheid H, Lapa C, Buck AK, Lassmann M, Werner RA (2017)
Absorbed dose estimates from a single measurement one to three days after the administration of 177Lu-DOTATATE/-TOC.
Nuklearmedizin. 56(6): 219-224 (Impact(2016)=1.087, Typ=Journal Article).

Kesner AL, Poli GL, Beykan S, Lassmann M (2017)
The IAEA Radiotracer Biodistribution Template - A community resource for supporting the standardization and reporting of radionuclide pre-dosimetry data.
Phys Med. 44: 83-85 (Impact(2016)=1.99, Typ=Journal Article).

Kircher M, Lapa C (2017)
Novel Noninvasive Nuclear Medicine Imaging Techniques for Cardiac Inflammation.
Curr Cardiovasc Imaging Rep. 10(2): 6 (Impact: liegt nicht vor, Typ=Journal Article; Review).

Kobayashi R, Chen X, Werner RA, Lapa C, Javadi MS, Higuchi T (2017)
New horizons in cardiac innervation imaging: introduction of novel F-labeled PET tracers.
Eur J Nucl Med Mol Imaging. 44(13): 2302-2309 (Impact(2016)=7.277, Typ=Journal Article).

Lapa C, Arias-Loza P, Hayakawa N, Wakabayashi H, Werner RA, Chen X, Shinaji T, Herrmann K, Pelzer T, Higuchi T (2017)
Whitening and Impaired Glucose Utilization of Brown Adipose Tissue in a Rat Model of Type 2 Diabetes Mellitus.
Sci Rep. 7(1): 16795 (Impact(2016)=4.259, Typ=Journal Article).

Lapa C, Garcia-Velloso MJ, Lückerath K, Samnick S, Schreder M, Otero PR, Schmid JS, Herrmann K, Knop S, Buck AK, Einsele H, San-Miguel J, Kortüm KM (2017)
(11)C-Methionine-PET in Multiple Myeloma: A Combined Study from Two Different Institutions.
Theranostics. 7(11): 2956-2964 (Impact(2016)=8.712, Typ=Article; Journal Article).

Lapa C, Herrmann K, Schirbel A, Hänscheid H, Lückerath K, Schottelius M, Kircher M, Werner RA, Schreder M, Samnick S, Kropf S, Knop S, Buck AK, Einsele H, Wester HJ, Kortüm KM (2017)
CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple Myeloma.
Theranostics. 7(6): 1589-1597 (Impact(2016)=8.712, Typ=Article; Journal Article).

Lapa C, Kircher S, Schirbel A, Rosenwald A, Kropf S, Pelzer T, Walles T, Buck AK, Weber WA, Wester HJ, Herrmann K, Lückerath K (2017)
Targeting CXCR4 with [Ga]Pentixafor: a suitable theranostic approach in pleural mesothelioma?
Oncotarget. 8(57): 96732-96737 (Impact(2016)=5.168, Typ=Journal Article).

Lapa C, Schirbel A, Samnick S, Lückerath K, Kortüm KM, Knop S, Wester HJ, Buck AK, Schreder M (2017)
The gross picture: intraindividual tumour heterogeneity in a patient with nonsecretory multiple myeloma.
Eur J Nucl Med Mol Imaging. 44(6): 1097-1098 (Impact(2016)=7.277, Typ=Editorial Material; Journal Article).

Lapa C, Schreder M, Schirbel A, Samnick S, Kortüm KM, Herrmann K, Kropf S, Einsele H, Buck AK, Wester HJ, Knop S, Lückerath K (2017)
[(68)Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [(18)F]FDG and laboratory values.
Theranostics. 7(1): 205-212 (Impact(2016)=8.712, Typ=Article; Journal Article).

Luster M, Pfestroff A, Hänscheid H, Verburg FA (2017)
Radioiodine Therapy.
Semin Nucl Med. 47(2): 126-134 (Impact: liegt nicht vor, Typ=Journal Article; Review).

Reich MM, Pozzi NG, Brumberg J, Åström M, Volkmann J, Isaias IU (2017)
Brain. 140(5): e28 (Impact(2016)=10.292, Typ=Journal Article).

Schottelius M, Osl T, Poschenrieder A, Hoffmann F, Beykan S, Hänscheid H, Schirbel A, Buck AK, Kropf S, Schwaiger M, Keller U, Lassmann M, Wester HJ (2017)
[Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic Agent.
Theranostics. 7(9): 2350-2362 (Impact(2016)=8.712, Typ=Journal Article).

Schwarzenboeck SM, Rauscher I, Bluemel C, Fendler WP, Rowe SP, Pomper MG, Asfhar-Oromieh A, Herrmann K, Eiber M (2017)
PSMA Ligands for PET Imaging of Prostate Cancer.
J Nucl Med. 58(10): 1545-1552 (Impact(2016)=6.646, Typ=Journal Article; Review).

Segerer FJ, Biko J, Reiners C, Wirth C, Hebestreit H (2017)
Exercise-Induced Hypoxemia in Juvenile Thyroid Carcinoma With Lung Metastases.
Pediatr Exerc Sci. 29(3): 361-370 (Impact(2016)=1.704, Typ=Article; Journal Article).

Sheikhbahaei S, Jones CS, Porter KK, Rowe SP, Gorin MA, Baras AS, Pierorazio PM, Ball MW, Higuchi T, Johnson PT, Solnes LB, Epstein JI, Allaf ME, Javadi MS (2017)
Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal Masses.
Clin Nucl Med. 42(4): e188-e193 (Impact(2016)=3.64, Typ=Journal Article; Evaluation Studies).

Verburg FA, Hänscheid H, Luster M (2017)
Radioactive iodine (RAI) therapy for metastatic differentiated thyroid cancer.
Best Pract Res Clin Endocrinol Metab. 31(3): 279-290 (Impact(2016)=4.466, Typ=Journal Article; Review).

Verburg FA, Luster M, Giovanella L, Lassmann M, Chiesa C, Chouin N, Flux G, EANM Thyroid, Radiation Protection and Dosimetry Committees (2017)
The "reset button" revisited: why high activity I therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patients.
Eur J Nucl Med Mol Imaging. 44(6): 915-917 (Impact(2016)=7.277, Typ=Comment; Editorial).

Verburg FA, Mäder U, Grelle I, Giovanella L, Reiners C, Hänscheid H (2017)
Only a Rapid Complete Biochemical Remission After 131I-Therapy is Associated with an Unimpaired Life Expectancy in Differentiated Thyroid Cancer.
Horm Metab Res. 49(11): 860-868 (Impact(2016)=2.268, Typ=Journal Article).

Walenkamp AME, Lapa C, Herrmann K, Wester HJ (2017)
CXCR4 Ligands: The Next Big Hit?
J Nucl Med. 58(Suppl 2): 77S-82S (Impact(2016)=6.646, Typ=Journal Article; Review).

Werner RA, Lapa C, Ilhan H, Higuchi T, Buck AK, Lehner S, Bartenstein P, Bengel F, Schatka I, Muegge DO, Papp L, Zsótér N, Große-Ophoff T, Essler M, Bundschuh RA (2017)
Survival prediction in patients undergoing radionuclide therapy based on intratumoral somatostatin-receptor heterogeneity.
Oncotarget. 8(4): 7039-7049 (Impact(2016)=5.168, Typ=Journal Article; Clinical Trial; Multicenter Study).

Werner R, Weich A, Higuchi T, Schmid J, Schirbel A, Lassmann M, Wild V, Rudelius M, Kudlich T, Herrmann K, Scheurlen M, Buck A, Kropf S, Wester HJ, Lapa C (2017)
Triple Tracer Imaging Approach for the Non-Invasive Assessment of Chemokine Receptor 4 Expression in Gastroenteropancreatic Neuroendocrine Tumors Neuroendocrinology. 105 1: 176-176 (Impact(2016)=3.608, Typ=Meeting Abstract).

Werner RA, Weich A, Higuchi T, Schmid JS, Schirbel A, Lassmann M, Wild V, Rudelius M, Kudlich T, Herrmann K, Scheurlen M, Buck AK, Kropf S, Wester HJ, Lapa C (2017)
Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative Approach. Theranostics. 7(6): 1489-1498 (Impact(2016)=8.712, Typ=Article; Journal Article).

Werner RA, Weich A, Schirbel A, Samnick S, Buck AK, Higuchi T, Wester HJ, Lapa C (2017)
Intraindividual tumor heterogeneity in NET - Further insight by C-X-C motif chemokine receptor 4-directed imaging.
Eur J Nucl Med Mol Imaging. 44(3): 553-554 (Impact(2016)=7.277, Typ=Editorial Material; Case Reports; Journal Article).

Wiyaporn K, Tocharoenchai C, Pusuwan P, Higuchi T, Fung GSK, Feng T, Park MJ, Tsui BMW (2017)
Optimization of imaging protocols for myocardial blood flow (MBF) quantification with F-flurpiridaz PET.
Phys Med. 42: 127-134 (Impact(2016)=1.99, Typ=Journal Article).

Zimmerman BE, Gro?ev D, Buvat I, Coca Pérez MA, Frey EC, Green A, Krisanachinda A, Lassmann M, Ljungberg M, Pozzo L, Quadir KA, Terán Gretter MA, Van Staden J, Poli GL (2017)
Multi-centre evaluation of accuracy and reproducibility of planar and SPECT image quantification: An IAEA phantom study.
Z Med Phys. 27(2): 98-112 (Impact(2016)=1.531, Typ=Journal Article; Multicenter Study).

Beykan S, Dam JS, Eberlein U, Kaufmann J, Kjærgaard B, Jødal L, Bouterfa H, Bejot R, Lassmann M, Jensen SB (2016)
(177)Lu-OPS201 targeting somatostatin receptors: in vivo biodistribution and dosimetry in a pig model.
EJNMMI Res 6(1):50.

Bluemel C, Kirchner P, Kajdi GW, Werner RA, Herrmann K (2016)
Localization of Parathyroid Adenoma With Real-Time Ultrasound: Freehand SPECT Fusion.
Clin Nucl Med 41(3):e141-2.

Bluemel C, Krebs M, Polat B, Linke F, Eiber M, Samnick S, Lapa C, Lassmann M, Riedmiller H, Czernin J, Rubello D, Bley T, Kropf S, Wester HJ, Buck AK, Herrmann K (2016)
68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT.
Clin Nucl Med 41(7):515-21.

Bluemel C, Linke F, Herrmann K, Simunovic I, Eiber M, Kestler C, Buck AK, Schirbel A, Bley TA, Wester HJ, Vergho D, Becker A (2016)
Impact of (68)Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy.
EJNMMI Res 6(1):78.

Bluemel C, Matthies P, Herrmann K, Povoski SP (2016)
3D scintigraphic imaging and navigation in radioguided surgery: freehand SPECT technology and its clinical applications.
Expert Rev Med Devices 13(4):339-51.

Bluemel C, Safak G, Cramer A, Wöckel A, Gesierich A, Hartmann E, Schmid JS, Kaiser F, Buck AK, Herrmann K (2016)
Fusion of freehand SPECT and ultrasound: First experience in preoperative localization of sentinel lymph nodes.
Eur J Nucl Med Mol Imaging 43(13):2304-2312.

Boschi S, Lee JT, Beykan S, Slavik R, Wei L, Spick C, Eberlein U, Buck AK, Lodi F, Cicoria G, Czernin J, Lassmann M, Fanti S, Herrmann K (2016)
Synthesis and preclinical evaluation of an Al(18)F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand.
Eur J Nucl Med Mol Imaging 43(12):2122-2130.
Buck A, Decristoforo C (2016)
Highlights lecture EANM 2015: the search for nuclear medicine's superheroes.
Eur J Nucl Med Mol Imaging 43(10):1910-27.

Canessa A, Pozzi NG, Arnulfo G, Brumberg J, Reich MM, Pezzoli G, Ghilardi MF, Matthies C, Steigerwald F, Volkmann J, Isaias IU (2016)
Striatal Dopaminergic Innervation Regulates Subthalamic Beta-Oscillations and Cortical-Subcortical Coupling during Movements: Preliminary Evidence in Subjects with Parkinson's Disease.
Front Hum Neurosci 10:611.

Carr Z, Clarke M, Akl EA, Schneider R, Murith C, Li C, Parrish-Sprowl J, Stenke L, Cui-Ping L, Bertrand S, Miller C (2016)
Using the Grade Approach to Support the Development of Recommendations for Public Health Interventions in Radiation Emergencies.
Radiat Prot Dosimetry 171(1):144-55.

de Galiza Barbosa F, Delso G, Ter Voert EE, Huellner MW, Herrmann K, Veit-Haibach P (2016)
Multi-technique hybrid imaging in PET/CT and PET/MR: what does the future hold?
Clin Radiol 71(7):660-72.

Dietlein M, Eschner W, Grünwald F, Lassmann M, Verburg FA, Luster M (2016)
Procedure guidelines for radioiodine therapy of differentiated thyroid cancer. Version 4.
Nuklearmedizin 55(3):77-89.

Dietlein M, Grünwald F, Schmidt M, Schneider P, Verburg FA, Luster M (2016)
Radioiodine therapy for benign thyroid diseases (version 5).
German Guideline. Nuklearmedizin 55(6):213-220.

Düwel C, Blümel C, Westenfelder K, Wagner-Thiessen E, Becker A, Gschwend JE, Eiber M, Maurer T (2016)
Rectal mucosa metastasis in recurrent prostate cancer : (68)Ga-PSMA-PET/CT allows targeted salvage radiotherapy.
Urologe A 55(8):1086-8.

Eberlein U, Scherthan H, Bluemel C, Peper M, Lapa C, Buck AK, Port M, Lassmann M (2016)
DNA Damage in Peripheral Blood Lymphocytes of Thyroid Cancer Patients After Radioiodine Therapy.
J Nucl Med 57(2):173-9.

Fahey FH, Bom HH, Chiti A, Choi YY, Huang G, Lassmann M, Laurin N, Mut F, Nuñez-Miller R, O'Keeffe D, Pradhan P, Scott AM, Song S, Soni N, Uchiyama M, Vargas L (2016)
Standardization of Administered Activities in Pediatric Nuclear Medicine: A Report of the First Nuclear Medicine Global Initiative Project, Part 2-Current Standards and the Path Toward Global Standardization.
J Nucl Med 57(7):1148-57.

Fanti S, Minozzi S, Castellucci P, Balduzzi S, Herrmann K, Krause BJ, Oyen W, Chiti A (2016)
PET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data.
Eur J Nucl Med Mol Imaging 43(1):55-69.

Fecher D, Hofmann E, Buck A, Bundschuh R, Nietzer S, Dandekar G, Walles T, Walles H, Lückerath K, Steinke M (2016)
Human Organotypic Lung Tumor Models: Suitable For Preclinical 18F-FDG PET-Imaging.
PLoS ONE 11(8):e0160282.
Heckl S, Reiners C, Buck AK, Schäfer A, Dick A, Scheurlen M (2016)
Evidence of impaired carbohydrate assimilation in euthyroid patients with Hashimoto's thyroiditis.
Eur J Clin Nutr 70(2):222-8.

Herrmann K, Schottelius M, Lapa C, Osl T, Poschenrieder A, Hänscheid H, Lückerath K, Schreder M, Bluemel C, Knott M, Keller U, Schirbel A, Samnick S, Lassmann M, Kropf S, Buck AK, Einsele H, Wester HJ, Knop S (2016)
First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease.
J Nucl Med 57(2):248-51.

Israel I, Ohsiek A, Al-Momani E, Albert-Weissenberger C, Stetter C, Mencl S, Buck AK, Kleinschnitz C, Samnick S, Sirén AL (2016)
Combined [(18)F]DPA-714 micro-positron emission tomography and autoradiography imaging of microglia activation after closed head injury in mice.
J Neuroinflammation 13(1):140.

Jakob F, Genest F, Seefried L, Tsourdi E, Lapa C, Hofbauer LC (2016)
Diagnostics in osteology].
Internist (Berl) 57(7):631-7.

Kestler C, Weng AM, Kunz AS, Laubmeier M, Wirth C, Köstler H, Bley TA, Veldhoen S (2016)
Acute Pulmonary Artery Embolism Detected by Noncontrast Functional Lung Magnetic Resonance Imaging.
Circ Cardiovasc Imaging 9(2):e004141.

Kroiss M, Plonné D, Kendl S, Schirmer D, Ronchi CL, Schirbel A, Zink M, Lapa C, Klinker H, Fassnacht M, Heinz W, Sbiera S (2016)
Association of mitotane with chylomicrons and serum lipoproteins: practical implications for treatment of adrenocortical carcinoma.
Eur J Endocrinol 174(3):343-53.

Lapa C, Hänscheid H, Wild V, Pelzer T, Schirbel A, Werner RA, Droll S, Herrmann K, Buck AK, Lückerath K (2016)
Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy.
Oncotarget 7(15):20033-40.

Lapa C, Knop S, Schreder M, Rudelius M, Knott M, Jörg G, Samnick S, Herrmann K, Buck AK, Einsele H, Lückerath K (2016)
(11)C-Methionine-PET in Multiple Myeloma: Correlation with Clinical Parameters and Bone Marrow Involvement.
Theranostics 6(2):254-61.

Lapa C, Lückerath K, Kleinlein I, Monoranu CM, Linsenmann T, Kessler AF, Rudelius M, Kropf S, Buck AK, Ernestus RI, Wester HJ, Löhr M, Herrmann K (2016)
(68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma.
Theranostics 6(3):428-34.

Lapa C, Lückerath K, Rudelius M, Schmid JS, Schoene A, Schirbel A, Samnick S, Pelzer T, Buck AK, Kropf S, Wester HJ, Herrmann K (2016)
[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer--initial experience.
Oncotarget 7(8):9288-95.

Lapa C, Reiter T, Kircher M, Schirbel A, Werner RA, Pelzer T, Pizarro C, Skowasch D, Thomas L, Schlesinger-Irsch U, Thomas D, Bundschuh RA, Bauer WR, Gärtner FC (2016)
Somatostatin receptor based PET/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI.
Oncotarget 7(47):77807-77814.

Lapa C, Werner RA, Herrmann K (2016)
Visualization of tumor heterogeneity in neuroendocrine tumors by positron emission tomography.
Endocrine 51(3):556-7.

Ljungberg M, Celler A, Konijnenberg MW, Eckerman KF, Dewaraja YK, Sjögreen-Gleisner K, SNMMI MIRD Committee , Bolch WE, Brill AB, Fahey F, Fisher DR, Hobbs R, Howell RW, Meredith RF, Sgouros G, Zanzonico P, EANM Dosimetry Committee , Bacher K, Chiesa C, Flux G, Lassmann M, Strigari L, Walrand S (2016)
MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy.
J Nucl Med 57(1):151-62.

Machado JS, Beykan S, Herrmann K, Lassmann M (2016)
Recommended administered activities for (68)Ga-labelled peptides in paediatric nuclear medicine.
Eur J Nucl Med Mol Imaging 43(11):2036-9.

Maya Y, Werner RA, Schütz C, Wakabayashi H, Samnick S, Lapa C, Zechmeister C, Jahns R, Jahns V, Higuchi T (2016)
11C-Methionine PET of Myocardial Inflammation in a Rat Model of Experimental Autoimmune Myocarditis.
J Nucl Med 57(12):1985-1990.

Nose N, Fukushima K, Lapa C, Werner RA, Javadi MS, Taki J, Higuchi T (2016)
Assessment of coronary flow reserve using a combination of planar first-pass angiography and myocardial SPECT: Comparison with myocardial (15)O-water PET.
Int J Cardiol 222:209-12.

Othman EM, Oli RG, Arias-Loza PA, Kreissl MC, Stopper H (2016)
Metformin Protects Kidney Cells From Insulin-Mediated Genotoxicity In Vitro and in Male Zucker Diabetic Fatty Rats.
Endocrinology 157(2):548-59.

Rasche L, Menoret E, Dubljevic V, Menu E, Vanderkerken K, Lapa C, Steinbrunn T, Chatterjee M, Knop S, Düll J, Greenwood DL, Hensel F, Rosenwald A, Einsele H, Brändlein S (2016)
A GRP78-Directed Monoclonal Antibody Recaptures Response in Refractory Multiple Myeloma with Extramedullary Involvement.
Clin Cancer Res 22(17):4341-9.

Reich MM, Brumberg J, Pozzi NG, Marotta G, Roothans J, Åström M, Musacchio T, Lopiano L, Lanotte M, Lehrke R, Buck AK, Volkmann J, Isaias IU (2016)
Progressive gait ataxia following deep brain stimulation for essential tremor: adverse effect or lack of efficacy?
Brain 139(11):2948-2956.

Reiners C, Schneider R, Akashi M, Akl EA, Jourdain JR, Li C, Murith C, Van Bladel L, Yamashita S, Zeeb H, Vitti P, Carr Z (2016)
The First Meeting of the WHO Guideline Development Group for the Revision of the WHO 1999 Guidelines for Iodine Thyroid Blocking.
Radiat Prot Dosimetry 171(1):47-56.

Sawatzky E, Al-Momani E, Kobayashi R, Higuchi T, Samnick S, Decker M (2016)
A Novel Way To Radiolabel Human Butyrylcholinesterase for Positron Emission Tomography through Irreversible Transfer of the Radiolabeled Moiety.
ChemMedChem 11(14):1540-50.

Scheidt HA, Haralampiev I, Theisgen S, Schirbel A, Sbiera S, Huster D, Kroiss M, Müller P (2016)
The adrenal specific toxicant mitotane directly interacts with lipid membranes and alters membrane properties depending on lipid composition.
Mol Cell Endocrinol 428:68-81.

Schmid JS, Schirbel A, Buck AK, Kropf S, Wester HJ, Lapa C (2016)
[68Ga]Pentixafor-Positron Emission Tomography/Computed Tomography Detects Chemokine Receptor CXCR4 Expression After Ischemic Stroke.
Circ Cardiovasc Imaging 9(9):e005217.

Sigurdson AJ, Brenner AV, Roach JA, Goudeva L, Müller JA, Nerlich K, Reiners C, Schwab R, Pfeiffer L, Waldenberger M, Braganza M, Xu L, Sturgis EM, Yeager M, Chanock SJ, Pfeiffer RM, Abend M, Port M (2016)
Selected single-nucleotide polymorphisms in FOXE1, SERPINA5, FTO, EVPL, TICAM1 and SCARB1 are associated with papillary and follicular thyroid cancer risk: replication study in a German population.
Carcinogenesis 37(7):677-684.

Spick C, Herrmann K, Czernin J (2016)
18F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients.
J Nucl Med 57(3):420-30.

Tran-Gia J, Bisdas S, Köstler H, Klose U (2016)
A model-based reconstruction technique for fast dynamic T1 mapping.
Magn Reson Imaging 34(3):298-307.

Tran-Gia J, Lohr D, Weng AM, Ritter CO, Stäb D, Bley TA, Köstler H (2016)
A model-based reconstruction technique for quantitative myocardial perfusion imaging. Magn Reson Med 76(3):880-7.

Tran-Gia J, Schlögl S, Lassmann M (2016)
Design and Fabrication of Kidney Phantoms for Internal Radiation Dosimetry Using 3D Printing Technology.
J Nucl Med 57(12):1998-2005.

Valls L, Badve C, Avril S, Herrmann K, Faulhaber P, O'Donnell J, Avril N (2016)
FDG-PET imaging in hematological malignancies.
Blood Rev 30(4):317-31.

Vrachimis A, Riemann B, Mäder U, Reiners C, Verburg FA (2016)
Endogenous TSH levels at the time ofI ablation do not influence ablation success, recurrence-free survival or differentiated thyroid cancer-related mortality. Eur J Nucl Med Mol Imaging 43(2):224-231.

Wakabayashi H, Werner RA, Hayakawa N, Javadi MS, Xinyu C, Herrmann K, Rowe SP, Lapa C, Higuchi T (2016)
Initial Preclinical Evaluation of 18F-Fluorodeoxysorbitol PET as a Novel Functional Renal Imaging Agent. J Nucl Med 57(10):1625-1628.

Werner RA, Beykan S, Higuchi T, Lückerath K, Weich A, Scheurlen M, Bluemel C, Herrmann K, Buck AK, Lassmann M, Lapa C, Hänscheid H (2016)
The impact of 177Lu-octreotide therapy on 99mTc-MAG3 clearance is not predictive for late nephropathy.
Oncotarget 7(27):41233-41241.

Werner RA, Kroiss M, Nakajo M, Mügge DO, Hahner S, Fassnacht M, Schirbel A, Bluemel C, Higuchi T, Papp L, Zsótér N, Buck AK, Bundschuh RA, Lapa C (2016)
Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomography.
Endocrine 53(3):791-800.

Werner RA, Lückerath K, Schmid JS, Higuchi T, Kreissl MC, Grelle I, Reiners C, Buck AK, Lapa C (2016)
Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment - initial experience.
Sci Rep 6:28081.

Werner RA, Maya Y, Rischpler C, Javadi MS, Fukushima K, Lapa C, Herrmann K, Higuchi T (2016)
Sympathetic nerve damage and restoration after ischemia-reperfusion injury as assessed by (11)C-hydroxyephedrine.
Eur J Nucl Med Mol Imaging 43(2):312-8.

Al-Momani E, Israel I, Buck AK, Samnick S (2015)
Improved synthesis of [¹⁸F]FS-PTAD as a new tyrosine-specific prosthetic group for radiofluorination of biomolecules.
Appl Radiat Isot 104:136-42.

Baur J, Schedelbeck U, Pulzer A, Bluemel C, Wild V, Fassnacht M, Steger U (2015)
A case report of a solitary pancreatic metastasis of an adrenocortical carcinoma.
BMC Surg 15:93.

Bluemel C, Cramer A, Grossmann C, Kajdi GW, Malzahn U, Lamp N, Langen HJ, Schmid J, Buck AK, Grimminger HJ, Herrmann K (2015)
iROLL: does 3-D radioguided occult lesion localization improve surgical management in early-stage breast cancer?
Eur J Nucl Med Mol Imaging 42(11):1692-9.

Bluemel C, Herrmann K, Giammarile F, Nieweg OE, Dubreuil J, Testori A, Audisio RA, Zoras O, Lassmann M, Chakera AH, Uren R, Chondrogiannis S, Colletti PM, Rubello D (2015)
EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma.
Eur J Nucl Med Mol Imaging 42(11):1750-66.

Bluemel C, Rubello D, Colletti PM, de Bree R, Herrmann K (2015)
Sentinel lymph node biopsy in oral and oropharyngeal squamous cell carcinoma: current status and unresolved challenges.
Eur J Nucl Med Mol Imaging 42(9):1469-80.

Chen X, Werner RA, Javadi MS, Maya Y, Decker M, Lapa C, Herrmann K, Higuchi T (2015)
Radionuclide imaging of neurohormonal system of the heart.
Theranostics 5(6)545-58.

Drozd VM, Saenko VA, Brenner AV, Drozdovitch V, Pashkevich VI, Kudelsky AV, Demidchik YE, Branovan I, Shiglik N, Rogounovitch TI, Yamashita S, Biko J, Reiners C (2015)
Major Factors Affecting Incidence of Childhood Thyroid Cancer in Belarus after the Chernobyl Accident: Do Nitrates in Drinking Water Play a Role?
PLoS ONE(10):9-e0137226.

Eberlein U, Nowak C, Bluemel C, Buck AK, Werner RA, Scherthan H, Lassmann M (2015)
DNA damage in blood lymphocytes in patients after (177)Lu peptide receptor radionuclide therapy.
Eur J Nucl Med Mol Imaging 42(11):1739-49.

Eberlein U, Peper M, Fernández M, Lassmann M, Scherthan H (2015)
Calibration of the ?-H2AX DNA double strand break focus assay for internal radiation exposure of blood lymphocytes.
PLoS ONE(10):4-e0123174.

Fahey FH, Bom HH, Chiti A, Choi YY, Huang G, Lassmann M, Laurin N, Mut F, Nuñez-Miller R, O'Keeffe D, Pradhan P, Scott AM, Song S, Soni N, Uchiyama M, Vargas L (2015)
Standardization of administered activities in pediatric nuclear medicine: a report of the first nuclear medicine global initiative project, part 1-statement of the issue and a review of available resources.
J Nucl Med 56(4):646-51.

Fendler WP, Chalkidis RP, Ilhan H, Knösel T, Herrmann K, Issels RD, Bartenstein P, Cyran CC, Lindner LH, Hacker M (2015)
Evaluation of several FDG PET parameters for prediction of soft tissue tumour grade at primary diagnosis and recurrence.
Eur Radiol 25(8):2214-21.

Fendler WP, Lehmann M, Todica A, Herrmann K, Knösel T, Angele MK, Dürr HR, Rauch J, Bartenstein P, Cyran CC, Hacker M, Lindner LH (2015)
PET response criteria in solid tumors predicts progression-free survival and time to local or distant progression after chemotherapy with regional hyperthermia for soft-tissue sarcoma.
J Nucl Med 56(4):530-7.

Fluri F, Grünstein D, Cam E, Ungethuem U, Hatz F, Schäfer J, Samnick S, Israel I, Kleinschnitz C, Orts-Gil G, Moch H, Zeis T, Schaeren-Wiemers N, Seeberger P (2015)
Fullerenols and glucosamine fullerenes reduce infarct volume and cerebral inflammation after ischemic stroke in normotensive and hypertensive rats.
Exp Neurol 265:142-51.

Foryst-Ludwig A, Kreissl MC, Benz V, Brix S, Smeir E, Ban Z, Januszewicz E, Salatzki J, Grune J, Schwanstecher AK, Blumrich A, Schirbel A, Klopfleisch R, Rothe M, Blume K, Halle M, Wolfarth B, Kershaw EE, Kintscher U (2015)
Adipose Tissue Lipolysis Promotes Exercise-induced Cardiac Hypertrophy Involving the Lipokine C16:1n7-Palmitoleate. J Biol Chem 290(39):23603-15.

Hänscheid H, Fernández M, Lassmann M (2015)
The absorbed dose to blood from blood-borne activity.
Phys Med Biol 60(2):741-53.

Herrmann K, Bluemel C, Weineisen M, Schottelius M, Wester HJ, Czernin J, Eberlein U, Beykan S, Lapa C, Riedmiller H, Krebs M, Kropf S, Schirbel A, Buck AK, Lassmann M (2015)
Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapy.
J Nucl Med 56(6)855-61.

Herrmann K, Czernin J, Wolin EM, Gupta P, Barrio M, Gutierrez A, Schiepers C, Mosessian S, Phelps ME, Allen-Auerbach MS (2015)
Impact of 68Ga-DOTATATE PET/CT on the management of neuroendocrine tumors: the referring physician's perspective.
J Nucl Med 56(1):70-5.

Herrmann K, Lapa C, Wester HJ, Schottelius M, Schiepers C, Eberlein U, Bluemel C, Keller U, Knop S, Kropf S, Schirbel A, Buck AK, Lassmann M (2015)
Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixafor.
J Nucl Med 56(3):410-6.

Herrmann K, Queiroz M, Huellner MW, de Galiza Barbosa F, Buck A, Schaefer N, Stolzman P, Veit-Haibach P (2015)
Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT.
BMC Cancer 15:1002.

Kläsner B, Buchmann N, Gempt J, Ringel F, Lapa C, Krause BJ (2015)
Early [18F]FET-PET in Gliomas after Surgical Resection: Comparison with MRI and Histopathology.
PLoS ONE(10):10-e0141153.

Kletting P, Schimmel S, Hänscheid H, Luster M, Fernández M, Nosske D, Lassmann M, Glatting G (2015)
The NUKDOS software for treatment planning in molecular radiotherapy.
Z Med Phys 25(3):264-74.

Kreissl MC, Fassnacht M, Mueller SP (2015)
Systemic treatment of advanced differentiated and medullary thyroid cancer.
Overview and practical aspects. Nuklearmedizin 54(3):88-93.

Lapa C, Linsenmann T, Lückerath K, Samnick S, Herrmann K, Stoffer C, Ernestus RI, Buck AK, Löhr M, Monoranu CM (2015)
Tumor-associated macrophages in glioblastoma multiforme-a suitable target for somatostatin receptor-based imaging and therapy?
PLoS ONE(10):3-e0122269.

Lapa C, Maya Y, Wagner M, Arias-Loza P, Werner RA, Herrmann K, Higuchi T (2015)
Activation of brown adipose tissue in hypothyroidism.
Ann Med 47(7):538-45.

Lapa C, Reiter T, Li X, Werner RA, Samnick S, Jahns R, Buck AK, Ertl G, Bauer WR (2015)
Imaging of myocardial inflammation with somatostatin receptor based PET/CT - A comparison to cardiac MRI.
Int J Cardiol 194:44-9.

Lapa C, Werner RA, Schmid JS, Papp L, Zsótér N, Biko J, Reiners C, Herrmann K, Buck AK, Bundschuh RA (2015)
Prognostic value of positron emission tomography-assessed tumor heterogeneity in patients with thyroid cancer undergoing treatment with radiopeptide therapy.
Nucl Med Biol 42(4)349-54.

Leonova TA, Drozd VM, Saenko VA, Mine M, Biko J, Rogounovitch TI, Takamura N, Reiners C, Yamashita S (2015)
Bone mineral density in treated at a young age for differentiated thyroid cancer after Chernobyl female patients on TSH-suppressive therapy receiving or not Calcium-D3 supplementation.
Endocr J 62(2):173-82.

Linz C, Müller-Richter UD, Buck AK, Mottok A, Ritter C, Schneider P, Metzen D, Heuschmann P, Malzahn U, Kübler AC, Herrmann K, Bluemel C (2015)
Performance of cone beam computed tomography in comparison to conventional imaging techniques for the detection of bone invasion in oral cancer.
Int J Oral Maxillofac Surg 44(1):8-15.

Lorenz R, Buck A, Reiners C (2015)
In-patient nuclear medicine therapy in Germany from 2010 to 2012. Analysis of structured quality reports.
Nuklearmedizin 54(2):61-8.

Lückerath K, Lapa C, Albert C, Herrmann K, Jörg G, Samnick S, Einsele H, Knop S, Buck AK (2015)
11C-Methionine-PET: a novel and sensitive tool for monitoring of early response to treatment in multiple myeloma.
Oncotarget 6(10):8418-29.

Macedo R, Javadi SM, Higuchi T, Carvalho MD, Medeiros Vde F, Azevedo ÍM, Lima FP, Medeiros AC (2015)
Heart and systemic effects of statin pretreatment in a rat model of abdominal sepsis. Assessment by Tc99m-sestamibi biodistribition.
Acta Cir Bras 30(6):388-93.

Maffione AM, Lopci E, Bluemel C, Giammarile F, Herrmann K, Rubello D (2015)
Diagnostic accuracy and impact on management of (18)F-FDG PET and PET/CT in colorectal liver metastasis: a meta-analysis and systematic review.
Eur J Nucl Med Mol Imaging 42(1):152-63.

Pacilio M, Amato E, Lanconelli N, Basile C, Torres LA, Botta F, Ferrari M, Diaz NC, Perez MC, Fernández M, Lassmann M, Gil AV, Cremonesi M (2015)
Differences in 3D dose distributions due to calculation method of voxel S-values and the influence of image blurring in SPECT.
Phys Med Biol 60(5):1945-64.

Paschke R, Lincke T, Müller SP, Kreissl MC, Dralle H, Fassnacht M (2015)
The Treatment of Well-Differentiated Thyroid Carcinoma.
Dtsch Arztebl Int 112(26):452-8.

Philipp-Abbrederis K, Herrmann K, Knop S, Schottelius M, Eiber M, Lückerath K, Pietschmann E, Habringer S, Gerngroß C, Franke K, Rudelius M, Schirbel A, Lapa C, Schwamborn K, Steidle S, Hartmann E, Rosenwald A, Kropf S, Beer AJ, Peschel C, Einsele H, Buck AK, Schwaiger M, Götze K, Wester HJ, Keller U (2015)
In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma.
EMBO Mol Med 7(4):477-87.

Porschen R, Buck A, Fischbach W, Gockel I, Görling U, Grenacher L, Hollerbach S, Hölscher A, Körber J, Messmann H, Meyer HJ, Miehlke S, Möhler M, Nöthlings U, Pech U, Schmidberger H, Schmidt M, Stahl M, Stuschke M, Thuss-Patience P, Trojan J, Vanhoefer U, Weimann A, Wenz F, Wullstein C (2015)
S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus.
Z Gastroenterol 53(11):1288-347.

Reiter T, Werner RA, Bauer WR, Lapa C (2015)
Detection of cardiac sarcoidosis by macrophage-directed somatostatin receptor 2-based positron emission tomography/computed tomography.
Eur Heart J 36(35):2404.

Rowe SP, Gorin MA, Gordetsky J, Ball MW, Pierorazio PM, Higuchi T, Epstein JI, Allaf ME, Javadi MS (2015)
Initial experience using 99mTc-MIBI SPECT/CT for the differentiation of oncocytoma from renal cell carcinoma.
Clin Nucl Med 40(4):309-13.

Sbiera S, Leich E, Liebisch G, Sbiera I, Schirbel A, Wiemer L, Matysik S, Eckhardt C, Gardill F, Gehl A, Kendl S, Weigand I, Bala M, Ronchi CL, Deutschbein T, Schmitz G, Rosenwald A, Allolio B, Fassnacht M, Kroiss M (2015)
Mitotane Inhibits Sterol-O-Acyl Transferase 1 Triggering Lipid-Mediated Endoplasmic Reticulum Stress and Apoptosis in Adrenocortical Carcinoma Cells.
Endocrinology 156(11):3895-908.

Schmidt T, Lordick F, Herrmann K, Ott K (2015)
Value of functional imaging by PET in esophageal cancer.
J Natl Compr Canc Netw 13(2)239-47.

Thomas L, Lapa C, Bundschuh RA, Polat B, Sonke JJ, Guckenberger M (2015)
Tumour delineation in oesophageal cancer - A prospective study of delineation in PET and CT with and without endoscopically placed clip markers.
Radiother Oncol 116(2)269-75.

Tillmanns J, Schneider M, Fraccarollo D, Schmitto JD, Länger F, Richter D, Bauersachs J, Samnick S (2015)
PET imaging of cardiac wound healing using a novel [68Ga]-labeled NGR probe in rat myocardial infarction.
Mol Imaging Biol 17(1)76-86.

Verburg FA, Mäder U, Luster M, Hänscheid H, Reiners C (2015)
Determinants of successful ablation and complete remission after total thyroidectomy and ¹³¹I therapy of paediatric differentiated thyroid cancer.
Eur J Nucl Med Mol Imaging 42(9):1390-8.

Weineisen M, Schottelius M, Simecek J, Baum RP, Yildiz A, Beykan S, Kulkarni HR, Lassmann M, Klette I, Eiber M, Schwaiger M, Wester HJ (2015)
68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies.
J Nucl Med 56(8):1169-76.

Werner RA, Bluemel C, Allen-Auerbach MS, Higuchi T, Herrmann K (2015)
68Gallium- and 90Yttrium-/ 177Lutetium: "theranostic twins" for diagnosis and treatment of NETs.
Ann Nucl Med 29(1):1-7.

Werner RA, Bluemel C, Lassmann M, Kudlich T, Higuchi T, Lopci E, Allen-Auerbach M, Colletti PM, Rubello D, Zatelli MC, Herrmann K (2015)
SPECT- and PET-based patient-tailored treatment in neuroendocrine tumors: a comprehensive multidisciplinary team approach.
Clin Nucl Med 40(5):e271-7.

Werner RA, Brumberg J, Dierks A, Herrmann K, Biko J, Buck AK, Lapa C (2015)
Paralytic subileus as an adverse effect of amino acid-based nephroprotection in a patient undergoing peptide receptor radionuclide therapy.
Clin Nucl Med 40(3):263-4.

Werner RA, Rischpler C, Onthank D, Lapa C, Robinson S, Samnick S, Javadi M, Schwaiger M, Nekolla SG, Higuchi T (2015)
Retention Kinetics of the 18F-Labeled Sympathetic Nerve PET Tracer LMI1195: Comparison with 11C-Hydroxyephedrine and 123I-MIBG.
J Nucl Med 56(9):1429-33.

Werner RA, Schmid JS, Muegge DO, Lückerath K, Higuchi T, Hänscheid H, Grelle I, Reiners C, Herrmann K, Buck AK, Lapa C (2015)
Prognostic Value of Serum Tumor Markers in Medullary Thyroid Cancer Patients Undergoing Vandetanib Treatment.
Medicine (Baltimore) 94(45):e2016.

Wester HJ, Keller U, Schottelius M, Beer A, Philipp-Abbrederis K, Hoffmann F, Šimeek J, Gerngross C, Lassmann M, Herrmann K, Pellegata N, Rudelius M, Kessler H, Schwaiger M (2015)
Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging.
Theranostics 5(6):618-30.

Bluemel C, Herrmann K, Kübler A, Buck AK, Geissinger E, Wild V, Hartmann S, Lapa C, Linz C, Müller-Richter U (2014)
Intraoperative 3-D imaging improves sentinel lymph node biopsy in oral cancer.
Eur J Nucl Med Mol Imaging 41(12):2257-64.

Bluemel C, Herrmann K, Müller-Richter U, Lapa C, Higuchi T, Wild V, Buck AK, Kübler A, Linz C (2014)
Freehand SPECT-guided sentinel lymph node biopsy in early oral squamous cell carcinoma.
Head Neck 36(11):E112-6.

Buder K, Lapa C, Kreissl MC, Schirbel A, Herrmann K, Schnack A, Bröcker EB, Goebeler M, Buck AK, Becker JC (2014)
Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging.
BMC Cancer 14:268.

Bundschuh RA, Dinges J, Neumann L, Seyfried M, Zsótér N, Papp L, Rosenberg R, Becker K, Astner ST, Henninger M, Herrmann K, Ziegler SI, Schwaiger M, Essler M (2014)
Textural Parameters of Tumor Heterogeneity in ¹?F-FDG PET/CT for Therapy Response Assessment and Prognosis in Patients with Locally Advanced Rectal Cancer.
J Nucl Med 55(6):891-7.

Ceci F, Herrmann K, Castellucci P, Graziani T, Bluemel C, Schiavina R, Vollmer C, Droll S, Brunocilla E, Mazzarotto R, Buck AK, Fanti S (2014)
Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial.
Eur J Nucl Med Mol Imaging 41(12):2222-31.

Chen DY, Schneider PF, Zhang XS, Luo XY, He ZM, Chen T (2014)
Changes in graves' ophthalmopathy after radioiodine and anti-thyroid drug treatment of Graves' disease from 2 prospective, randomized, open-label, blinded end point studies.
Exp Clin Endocrinol Diabetes 122(1):1-6.

Graf N, Li Z, Herrmann K, Weh D, Aichler M, Slawska J, Walch A, Peschel C, Schwaiger M, Buck AK, Dechow T, Keller U (2014)
Positron emission tomographic monitoring of dual phosphatidylinositol-3-kinase and mTOR inhibition in anaplastic large cell lymphoma.
Onco Targets Ther 7:789-98.

Hänscheid H, Fernández M, Eberlein U, Lassmann M (2014)
Self-irradiation of the blood from selected nuclides in nuclear medicine.
Phys Med Biol 59(6):1515-31.

Hänscheid H, Lassmann M, Buck AK, Reiners C, Verburg FA (2014)
The limit of detection in scintigraphic imaging with I-131 in patients with differentiated thyroid carcinoma.
Phys Med Biol 59(10):2353-68.

Heger U, Bader F, Lordick F, Burian M, Langer R, Dobritz M, Blank S, Bruckner T, Becker K, Herrmann K, Siewert JR, Ott K (2014)
Interim endoscopy results during neoadjuvant therapy for gastric cancer correlate with histopathological response and prognosis.
Gastric Cancer 17(3):478-88.

Herrmann K, Buck AK, Schuster T, Abbrederis K, Blümel C, Santi I, Rudelius M, Wester HJ, Peschel C, Schwaiger M, Dechow T, Keller U (2014)
Week one FLT-PET response predicts complete remission to R-CHOP and survival in DLBCL.
Oncotarget 5(12):4050-9.

Herrmann K, Czernin J, Cloughesy T, Lai A, Pomykala KL, Benz MR, Buck AK, Phelps ME, Chen W. (2014) Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients. Neuro-oncol 16(4):603-9.

Isaias IU, Spiegel J, Brumberg J, Cosgrove KP, Marotta G, Oishi N, Higuchi T, Küsters S, Schiller M, Dillmann U, van Dyck CH, Buck A, Herrmann K, Schloegl S, Volkmann J, Lassmann M, Fassbender K, Lorenz R, Samnick S (2014)
Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's disease.
Front Aging Neurosci 6:13.

Israel I, Richter D, Stritzker J, van Ooschot M, Donat U, Buck AK, Samnick S (2014)
PET imaging with [⁶⁸Ga]NOTA-RGD for prostate cancer: a comparative study with [¹⁸F]fluorodeoxyglucose and [¹⁸F]fluoroethylcholine.
Curr Cancer Drug Targets 14(4):371-9.

Karantanis D, Kalkanis D, Czernin J, Herrmann K, Pomykala KL, Bogsrud TV, Subramaniam RM, Lowe VJ, Allen-Auerbach MS (2014)
Perceived misinterpretation rates in oncologic 18F-FDG PET/CT studies: a survey of referring physicians.
J Nucl Med 55(12):1925-9.

Krohn T, Hänscheid H, Müller B, Behrendt FF, Heinzel A, Mottaghy FM, Verburg FA (2014)
Maximum dose rate is a determinant of hypothyroidism after 131I therapy of Graves' disease but the total thyroid absorbed dose is not.
J Clin Endocrinol Metab    99(11):4109-15.

Lapa C, Linsenmann T, Monoranu CM, Samnick S, Buck AK, Bluemel C, Czernin J, Kessler AF, Homola GA, Ernestus RI, Löhr M, Herrmann K (2014)
Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.
J Nucl Med 55(10):1611-6.

Lapa C, Linz C, Bluemel C, Mottok A, Mueller-Richter U, Kuebler A, Schneider P, Czernin J, Buck AK, Herrmann K (2014)
Three-phase bone scintigraphy for imaging osteoradionecrosis of the jaw.
Clin Nucl Med 39(1):21-5.

Lapa C, Lückerath K, Malzahn U, Samnick S, Einsele H, Buck AK, Herrmann K, Knop S (2014)
18 FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation.
Oncotarget 5(17):7381-91.

Lassmann M, Treves ST, EANM/SNMMI Paediatric Dosage Harmonization Working Group , Boellaard R, Bolch W, Borgwardt L, Chiti A, Fahey F, Gelfand M, Lassmann M, Parisi M, Pfluger T, Spottswood S, Treves ST (2014)
Paediatric radiopharmaceutical administration: harmonization of the 2007 EANM paediatric dosage card (version 1.5.2008) and the 2010 North American consensus guidelines.
Eur J Nucl Med Mol Imaging 41(5):1036-41.

Li X, Bauer W, Israel I, Kreissl MC, Weirather J, Richter D, Bauer E, Herold V, Jakob P, Buck A, Frantz S, Samnick S (2014)
Targeting P-selectin by gallium-68-labeled fucoidan positron emission tomography for noninvasive characterization of vulnerable plaques: correlation with in vivo 17.6T MRI.
Arterioscler Thromb Vasc Biol 34(8):1661-7.

Lorenz R, Samnick S, Dillmann U, Schiller M, Ong MF, Faßbender K, Buck A, Spiegel J (2014)
Nicotinic α4β2 acetylcholine receptors and cognitive function in Parkinson's disease.
Acta Neurol Scand 130(3):164-71.

Mencacci NE, Isaias IU, Reich MM, Ganos C, Plagnol V, Polke JM, Bras J, Hersheson J, Stamelou M, Pittman AM, Noyce AJ, Mok KY, Opladen T, Kunstmann E, Hodecker S, Münchau A, Volkmann J, Samnick S, Sidle K, Nanji T, Sweeney MG, Houlden H, Batla A, Zecchinelli AL, Pezzoli G, Marotta G, Lees A, Alegria P, Krack P, Cormier-Dequaire F, Lesage S, Brice A, Heutink P, Gasser T, Lubbe SJ, Morris HR, Taba P, Koks S, Majounie E, Raphael Gibbs J, Singleton A, Hardy J, Klebe S, Bhatia KP, Wood NW, International Parkinson's Disease Genomics Consortium and UCL-exomes consortium (2014)
Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.
Brain 137(Pt 9):2480-92.

Ott K, Schmidt T, Lordick F, Herrmann K (2014)
Importance of PET in surgery of esophageal cancer.
Chirurg 85(6):505-12.

Richter D, Basse-Lüsebrink TC, Kampf T, Fischer A, Israel I, Schneider M, Jakob PM, Samnick S (2014)
Compressed sensing for reduction of noise and artefacts in direct PET image reconstruction.
Z Med Phys 24(1):16-26.

Schneider PF, Biko J, Varazashvili L, Neumann S (2014)
β-Radiation exposure to fingertips after using a trained routine application method during radiosynovectomy.
Nucl Med Commun 35(11):1175-8.

Strigari L, Konijnenberg M, Chiesa C, Bardies M, Du Y, Gleisner KS, Lassmann M, Flux G (2014)
The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy.
Eur J Nucl Med Mol Imaging 41(10):1976-88.

Sweeney R, Polat B, Samnick S, Reiners C, Flentje M, Verburg FA (2014)
O-(2-[(18)F]fluoroethyl)-L-tyrosine uptake is an independent prognostic determinant in patients with glioma referred for radiation therapy.
Ann Nucl Med 28(2)154-62.

Thies ED, Tanase K, Maeder U, Luster M, Buck AK, Hänscheid H, Reiners C, Verburg FA (2014)
The number of 131I therapy courses needed to achieve complete remission is an indicator of prognosis in patients with differentiated thyroid carcinoma.
Eur J Nucl Med Mol Imaging 41(12):2281-90.

Verburg FA, Mäder U, Grelle I, Visser TJ, Peeters RP, Smit JW, Reiners C (2014)
The thyroid axis 'setpoints' are significantly altered after long-term suppressive LT4 therapy.
Horm Metab Res 46(11):794-9.

Verburg FA, Mäder U, Reiners C, Hänscheid H (2014)
Long-term survival in differentiated thyroid cancer is worse after low-activity initial post-surgical 131I therapy in both high- and low-risk patients.
J Clin Endocrinol Metab 99(12):4487-96.

Werner RA, Bluemel C, Lapa C, Muegge DO, Kudlich T, Buck AK, Herrmann K (2014)
Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?
Nucl Med Commun 35(11):1143-9.

Wieder HA, Pomykala KL, Benz MR, Buck AK, Herrmann K (2014)
PET tracers in musculoskeletal disease beyond FDG.
Semin Musculoskelet Radiol 18(2):123-32.

Wiegering A, Herrmann K, Bluemel C, Buck AK, Germer CT (2014)
Importance of FDG-PET/CT for surgery of rectal cancer.
Chirurg 85(6):487-92.

Wurmb T, Kühne CA, Schneider R (2014)
In-hospitaltraumamanagement - radiation emergency and multiple trauma - principals of treatment in the emergency room.
Anasthesiol Intensivmed Notfallmed Schmerzther 49(9):556-9.

Yamane T, Park MJ, Richter D, Nekolla SG, Javadi MS, Lapa C, Samnick S, Buck AK, Herrmann K, Higuchi T (2014)
Small-animal PET imaging of isolated perfused rat heart.
J Nucl Med 55(3):495-9.

Al-Ibraheem A, Buck AK, Benz MR, Rudert M, Beer AJ, Mansour A, Pomykala KL, Haller B, Juenger H, Scheidhauer K, Schwaiger M, Herrmann K (2013)
(18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.
Cancer 119(6):1227-34.

Berger ML, Hammerschmidt F, Qian R, Hahner S, Schirbel A, Stichelberger M, Schibli R, Yu J, Arion VB, Woschek A, Öhler E, Zolle IM (2013)
[(3)H]metyrapol and 4-[(131)i]iodometomidate label overlapping, but not identical, binding sites on rat adrenal membranes.
Mol Pharm 10(3):1119-30.

Bluemel C, Lapa C, Mottok A, Hahner S, Herrmann K (2013)
Tumor localization in ectopic Cushing syndrome using combined PET/CT imaging.
Clin Nucl Med 38 (9):749-51.

Bluemel C, Schnelzer A, Okur A, Ehlerding A, Paepke S, Scheidhauer K, Kiechle M (2013)
Freehand SPECT for image-guided sentinel lymph node biopsy in breast cancer.

Bundschuh RA, Wendl CM, Weirich G, Eiber M, Souvatzoglou M, Treiber U, Kübler H, Maurer T, Gschwend JE, Geinitz H, Grosu AL, Ziegler SI, Krause BJ (2013)
Tumour volume delineation in prostate cancer assessed by [11C]choline PET/CT: validation with surgical specimens.
Eur J Nucl Med Mol Imaging 40(7):1126-34.

Del Guerra A, Bardies M, Belcari N, Caruana CJ, Christofides S, Erba P, Gori C, Lassmann M, Lonsdale MN, Sattler B, Waddington W (2013)
Curriculum for education and training of medical physicists in nuclear medicine: recommendations from the EANM Physics Committee, the EANM Dosimetry Committee and EFOMP.
Phys Med 29(2):139-62.

Dießl S, Verburg F, Biko J, Schryen B, Reiners C, Buck A, Hänscheid H (2013)
Improved follow-up of patients with differentiated thyroid carcinoma. The quantitative detection limit of 131I uptake in diagnostic scans.
Nuklearmedizin 52(3):81-7.

Dörr JR, Yu Y, Milanovic M, Beuster G, Zasada C, Däbritz JH, Lisec J, Lenze D, Gerhardt A, Schleicher K, Kratzat S, Purfürst B, Walenta S, Mueller-Klieser W, Gräler M, Hummel M, Keller U, Buck AK, Dörken B, Willmitzer L, Reimann M, Kempa S, Lee S, Schmitt CA (2013)
Synthetic lethal metabolic targeting of cellular senescence in cancer therapy.
Nature 501(7467):421-5.

Eberlein U, Lassmann M (2013)
Dosimetry of [⁶⁸Ga]-labeled compounds.
Appl Radiat Isot 76:70-4.

Elisei R, Schlumberger MJ, Müller SP, Schöffski P, Brose MS, Shah MH, Licitra L, Jarzab B, Medvedev V, Kreissl MC, Niederle B, Cohen EE, Wirth LJ, Ali H, Hessel C, Yaron Y, Ball D, Nelkin B, Sherman SI (2013)
Cabozantinib in progressive medullary thyroid cancer.
J Clin Oncol 31(29):3639-46.

Essler M, Wantke J, Mayer B, Scheidhauer K, Bundschuh RA, Haller B, Astner ST, Molls M, Andratschke N (2013)
Positron-emission tomography CT to identify local recurrence in stage I lung cancer patients 1 year after stereotactic body radiation therapy.
Strahlenther Onkol 189(6):495-501.

Eur J Nucl Med Mol Imaging 40(11):1656-61.

Fernández M, Hänscheid H, Mauxion T, Bardiès M, Kletting P, Glatting G, Lassmann M (2013)
A fast method for rescaling voxel S values for arbitrary voxel sizes in targeted radionuclide therapy from a single Monte Carlo calculation.
Med Phys 40(8):082502.

Frank-Raue K, Machens A, Leidig-Bruckner G, Rondot S, Haag C, Schulze E, Lorenz A, Kreissl MC, Dralle H, Raue F, Schmid KW (2013)
Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma.
Thyroid 23 (3):294-300.

Glatting G, Bardiès M, Lassmann M (2013)
Treatment planning in molecular radiotherapy.
Z Med Phys 23(4):262-9.

Graf N, Herrmann K, Numberger B, Zwisler D, Aichler M, Feuchtinger A, Schuster T, Wester HJ, Senekowitsch-Schmidtke R, Peschel C, Schwaiger M, Keller U, Dechow T, Buck AK (2013)
[18F]FLT is superior to [18F]FDG for predicting early response to antiproliferative treatment in high-grade lymphoma in a dose-dependent manner.

Grande E, Kreissl MC, Filetti S, Newbold K, Reinisch W, Robert C, Schlumberger M, Tolstrup LK, Zamorano JL, Capdevila J (2013)
Vandetanib in advanced medullary thyroid cancer: review of adverse event management strategies.
Adv Ther  30(11):945-66.

Hahner S, Kreissl MC, Fassnacht M, Haenscheid H, Bock S, Verburg FA, Knoedler P, Lang K, Reiners C, Buck AK, Allolio B, Schirbel A
 (2013)
Functional characterization of adrenal lesions using [123I]IMTO-SPECT/CT.

J Clin Endocrinol Metab 98(4):1508-18.

Hänscheid H, Canzi C, Eschner W, Flux G, Luster M, Strigari L, Lassmann M (2013)
EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry II.
Dosimetry prior to radioiodine therapy of benign thyroid diseases.

Herrmann K, Dahlbom M, Nathanson D, Wei L, Radu C, Chatziioannou A, Czernin J. (2013)
Evaluation of the Genisys4, a bench-top preclinical PET scanner.
J Nucl Med    54(7):1162-7.

Higuchi T, Yousefi BH, Kaiser F, Gärtner F, Rischpler C, Reder S, Yu M, Robinson S, Schwaiger M, Nekolla SG (2013)
Assessment of the 18F-labeled PET tracer LMI1195 for imaging norepinephrine handling in rat hearts.
J Nucl Med 54(7):1142-6.

Horm Metab Res 45(10):728-35.

Is the image quality of I-124-PET impaired by an automatic correction of prompt gammas? PLoS ONE 8(8):e71729.

Jurowich CF, Rikkala PR, Thalheimer A, Wichelmann C, Seyfried F, Sander V, Kreissl M, Germer CT, Koepsell H, Otto C (2013)
Duodenal-jejunal bypass improves glycemia and decreases SGLT1-mediated glucose absorption in rats with streptozotocin-induced type 2 diabetes.
Ann Surg 258(1):89-97.

Kletting P, Schimmel S, Kestler HA, Hänscheid H, Luster M, Fernández M, Bröer JH, Nosske D, Lassmann M, Glatting G (2013)
Molecular radiotherapy: the NUKFIT software for calculating the time-integrated activity coefficient.
Med Phys 40(10):102504.

Koehler C, Ginzkey C, Kleinsasser NH, Hagen R, Reiners C, Verburg FA (2013)
Short-term severe thyroid hormone deficiency does not influence sleep parameters.
Sleep Breath 17(1):253-8.

Kossert K, Jörg G, Gostomski CL (2013)
Experimental half-life determination of ¹⁷⁶Lu.
Appl Radiat Isot 81:140-5.

Kreissl MC, Schirbel A, Fassnacht M, Haenscheid H, Verburg FA, Bock S, Saeger W, Knoedler P, Reiners C, Buck AK, Allolio B, Hahner S (2013)
[¹²³I]Iodometomidate imaging in adrenocortical carcinoma.
J Clin Endocrinol Metab 98(7):2755-64.

Lassmann M, Nosske D (2013)
Dosimetry of 223Ra-chloride: dose to normal organs and tissues. Dosimetry of 223Ra-chloride: dose to normal organs and tissues.
Eur J Nucl Med Mol Imaging 40(2):207-12.

Li X, Bauer W, Kreissl MC, Weirather J, Bauer E, Israel I, Richter D, Riehl G, Buck A, Samnick S (2013)
Specific somatostatin receptor II expression in arterial plaque: (68)Ga-DOTATATE autoradiographic, immunohistochemical and flow cytometric studies in apoE-deficient mice.
Atherosclerosis 230(1):33-9.

Lonsdale MN, Lassmann M (2013)
EANM perspective.
Radiat Prot Dosimetry 153(2):166-9.

Lückerath K, Lapa C, Spahmann A, Jörg G, Samnick S, Rosenwald A, Einsele H, Knop S, Buck AK (2013)
Targeting paraprotein biosynthesis for non-invasive characterization of myeloma biology.
PLoS ONE(8):12-e84840.

Othman EM, Kreissl MC, Kaiser FR, Arias-Loza PA, Stopper H (2013)
Insulin-mediated oxidative stress and DNA damage in LLC-PK1 pig kidney cell line, female rat primary kidney cells, and male ZDF rat kidneys in vivo.
Endocrinology 154(4):1434-43.

Preylowski V, Schlögl S, Schoenahl F, Jörg G, Samnick S, Buck AK, Lassmann M (2013)

Reiners C, Biko J, Haenscheid H, Hebestreit H, Kirinjuk S, Baranowski O, Marlowe RJ, Demidchik E, Drozd V, Demidchik Y (2013)
Twenty-five years after Chernobyl: outcome of radioiodine treatment in children and adolescents with very high-risk radiation-induced differentiated thyroid carcinoma.
J Clin Endocrinol Metab 98(7):3039-48.

Reiners C, Schneider R (2013)
Potassium iodide (KI) to block the thyroid from exposure to I-131: current questions and answers to be discussed.
Radiat Environ Biophys 52(2):189-93.

Rendl S, Lapa C, Blümel C, Bundschuh RA, Schneider P (2013)
Decision making for osteoporotic treatment using FRAX or DVO risk algorithms in a clinical setting.
J Musculoskelet Neuronal Interact 13(3):339-45.

Rischpler C, Fukushima K, Isoda T, Javadi MS, Dannals RF, Abraham R, Wahl R, Bengel FM, Higuchi T (2013)
Discrepant uptake of the radiolabeled norepinephrine analogues hydroxyephedrine (HED) and metaiodobenzylguanidine (MIBG) in rat hearts.
Eur J Nucl Med Mol Imaging 40(7):1077-83.

Verburg FA, Hartmann D, Grelle I, Giovanella L, Buck AK, Reiners C (2013)
Relationship between antithyroglobulin autoantibodies and thyroglobulin recovery rates using different thyroglobulin concentrations in the recovery buffer.

Verburg FA, Mäder U, Tanase K, Thies ED, Diessl S, Buck AK, Luster M, Reiners C (2013)
Life expectancy is reduced in differentiated thyroid cancer patients >= 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients.
J Clin Endocrinol Metab 98(1):172-80.

Verburg FA, Reiners C, Grelle I, Barth H, Fassnacht M, Luster M (2013)
Calcium stimulated calcitonin measurement: a procedural proposal.
Exp Clin Endocrinol Diabetes 121(5):318-20.

Verburg FA, Reiners C, Hänscheid H (2013)
Approach to the patient: role of dosimetric RAI Rx in children with DTC.
J Clin Endocrinol Metab 98(10):3912-9.

Verburg FA, Sweeney R, Hänscheid H, Dießl S, Israel I, Löhr M, Vince GH, Flentje M, Reiners C, Samnick S (2013)
Patients with recurrent glioblastoma multiforme. Initial experience with p-[(131)I]iodo-L-phenylalanine and external beam radiation therapy.
Nuklearmedizin 52(1):36-42.

Angheloiu GO, Hänscheid H, Wen X, Capponi V, Anderson WD, Kellum JA (2012)
Experimental first-pass method for testing and comparing sorbent polymers used in the clearance of iodine contrast materials.
Blood Purif 34(1):34-9.

Bundschuh RA, Andratschke N, Dinges J, Duma MN, Astner ST, Brügel M, Ziegler SI, Molls M, Schwaiger M, Essler M (2012)
Respiratory gated [18F]FDG PET/CT for target volume delineation in stereotactic radiation treatment of liver metastases.
Strahlenther Onkol 188(7):592-8.

Chen DY, Schneider PF, Zhang XS, He ZM, Chen TH (2012)
Fatality after cardiac arrest in thyrotoxic periodic paralysis due to profound hypokalemia resulting from intravenous glucose administration and inadequate potassium replacement.
Thyroid 22(9):969-72.

Chen DY, Schneider PF, Zhang XS, He ZM, Jing J, Chen TH (2012)
Mental health status and factors that influence the course of Graves' disease and antithyroid treatments.
Exp Clin Endocrinol Diabetes 120(9):524-8.

Chiesa C, Luster M, Lassmann M (2012)
4th international symposium on targeted radiotherapy and dosimetry (ISTARD): best ranked abstract publication.
Q J Nucl Med Mol Imaging 56(6):485-6.

Diessl S, Holzberger B, Mäder U, Grelle I, Smit JW, Buck AK, Reiners C, Verburg FA. (2012) Impact of moderate vs stringent TSH suppression on survival in advanced differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 76(4):586-92.

Giovanella L, Ceriani L, De Palma D, Suriano S, Castellani M, Verburg FA (2012)
Relationship between serum thyroglobulin and 18FDG-PET/CT in 131I-negative differentiated thyroid carcinomas.
Head Neck 34(5):626-31.

Hahner S, Kreissl MC, Fassnacht M, Haenscheid H, Knoedler P, Lang K, Buck AK, Reiners C, Allolio B, Schirbel A (2012)
[131I]iodometomidate for targeted radionuclide therapy of advanced adrenocortical carcinoma.
J Clin Endocrinol Metab 97(3):914-22.

Hänscheid H, Sweeney RA, Flentje M, Buck AK, Löhr M, Samnick S, Kreissl M, Verburg FA (2012)
PET SUV correlates with radionuclide uptake in peptide receptor therapy in meningioma.
Eur J Nucl Med Mol Imaging 39(8):1284-8.

Hempel K, Haenscheid H, Biko J, Hategan M, Kaiser F, Kreissl M, Lorenz R, Samnick S, Schirbel A, Varazashvili L, Verchenya S, Reiners C (2012)
Frequency of transferrin receptor positive reticulocytes (TF-Ret) in blood as an indicator of total-body radiation exposure: a pilot study in nuclear medicine patients.
Radiat Res 178(5):481-8.

Herrmann K, Erkan M, Dobritz M, Schuster T, Siveke JT, Beer AJ, Wester HJ, Schmid RM, Friess H, Schwaiger M, Kleeff J, Buck AK (2012)
Comparison of 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours.
Eur J Nucl Med Mol Imaging    39(5):846-51.

Kreissl MC, Hänscheid H, Löhr M, Verburg FA, Schiller M, Lassmann M, Reiners C, Samnick SS, Buck AK, Flentje M, Sweeney RA (2012)
Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma.
Radiat Oncol 7:99.

Li Z, Graf N, Herrmann K, Jünger A, Aichler M, Feuchtinger A, Baumgart A, Walch A, Peschel C, Schwaiger M, Buck A, Keller U, Dechow T (2012)
FLT-PET is superior to FDG-PET for very early response prediction in NPM-ALK-positive lymphoma treated with targeted therapy.
Cancer Res 72(19):5014-24.

Morbach H, Schneider P, Schwarz T, Hofmann C, Raab P, Neubauer H, Düren C, Beer M, Girschick HJ (2012)
Comparison of magnetic resonance imaging and 99mTechnetium-labelled methylene diphosphonate bone scintigraphy in the initial assessment of chronic non-bacterial osteomyelitis of childhood and adolescents.
Clin Exp Rheumatol 30(4):578-82.

Schneider R, Schneider M, Reiners C, Schneider P (2012)
Effects of levothyroxine on bone mineral density, muscle force, and bone turnover markers: a cohort study.
J Clin Endocrinol Metab 97(11)3926-34.

Spallek L, Krille L, Reiners C, Schneider R, Yamashita S, Zeeb H (2012)
Adverse effects of iodine thyroid blocking: a systematic review.
Radiat Prot Dosimetry 150(3):267-77.

Verburg FA, Grelle I, Giovanella L, Reiners C (2012)
Evaluation of the BRAHMS KRYPTOR thyroglobulin "mini-recovery" test in thyroid healthy subjects.
Horm Metab Res 44(7):555-7.

Verburg FA, Smit JW, Grelle I, Visser TJ, Peeters RP, Reiners C. (2012) Changes within the thyroid axis after long-term TSH-suppressive levothyroxine therapy.  Clin Endocrinol (Oxf) 76(4):577-81.

Zahn RK, Frey S, Jakubietz RG, Jakubietz MG, Doht S, Schneider P, Waschke J, Meffert RH (2012)
A contoured locking plate for distal fibular fractures in osteoporotic bone: a biomechanical cadaver study.
Injury 43(6):718-25.